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INTRODUCTION 
Gestational diabetes mellitus means hyperglycemia in pregnancy.By 
definition it is “carbohydrate intolerance with onset or first recognition during 
pregnancy”¹. In recent times there is increasing prevalence of pregnancies 
complicated by gestational diabetes mellitus. The worldwide prevalence ranges 
between 11-14%. The prevalence is slightly higher in the Indian population 
(16.5%) 2, as we Indians are inherently more vulnerable to get affected owing to 
our hereditary and genetic make up and ethnicity.  
The condition occurs exclusively in the antenatal period where there is 
certain physiological maladaptation in the regulation of carbohydrate 
metabolism in pregnancy that turns out to be pathological, contributing to the 
onset and progression of the condition. It can cause a wide range of 
complications as well as long term implications in both the mother and fetus. 
The severity of the condition should not be overlooked. The International 
Diabetic Federation found that one out of seven births in India is affected by 
GDM. A large proportion of women also progress to become overt diabetics in 
the future hampering their quality of life by causing morbidity in various forms. 
This study was undertaken to evaluate the maternal and fetal 
complications and postpartum glucose intolerance in patients with Gestational 
Diabetes Mellitus Chengalpattu Medical College Hospital, Chengalpattu in a 
period of 1year from October 2016 to September 2017. 
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AIMS AND OBJECTIVE 
 To study the prevalence of antepartum ,intrapartum and postpartum 
complications in patients with Gestational diabetes mellitus 
 To study the outcome of pregnancy in patients with Gestational diabetes 
mellitus 
 To study the incidence of patients with glucose intolerance/overt diabetes 
mellitus during the postpartum follow up of patients with Gestational 
diabetes mellitus 
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REVIEW OF LITERATURE 
The first prospective study on metabolism of carbohydrates in pregnancy 
was established in Boston in 1954,by using 50 gram 1 hour screening test 3. At 
that time,the US emphasis was on establishing criteria for the 100g Oral glucose 
tolerance test in pregnancy as an index of subsequent risk of the mother 
developing established Diabetes, and the well known O’Sullivan criteria were 
derived on this basis2.O’Sullivan christened the name “Gestational Diabetes 
Mellitus”. Formerly it was called metagestational diabetes mellitus4. Jorgen 
Pederson used the term “Gestational Diabetes”in his monograph5 in 1967,but 
branded the mother to have gestational diabetes mellitus only after delivery.He 
found out that abnormal tolerance to carbohydrates especially glucose returned 
to normal in the postpartum period. The enthusiasm of the team led by Norbert 
Freinkel and subsequently by Boyd Metzger has ensured that the concept of 
Gestational diabetes is firmly imprinted on the obstetric mind,as well as having 
established a major place as an epidemiological tool to study not only the 
immediate outcome of pregnancy but also the long term effects on both mother 
and baby of the relatively short phase of hyperglycemia during the later part of 
pregnancy. 
Peter Damm6 studied the prognosis of women with GDM in previous 
pregnancy with respect to subsequent development of diabetes and also of 
predictive factors for developmentof overt diabetes in these women. Insulin 
4 
 
sensitivity in glucose tolerant non obese women with previous GDM were 
compared with controls. It was found that even these women are characterized 
by metabolic profile of type 2 Diabetes. Therefore all women with previous 
history of GDM should have regular assessment of their glucose tolerance in 
their years after pregnancy. 
FREINKELS CONCEPT OF METABOLIC REGULATION IN 
PREGNANCY 
Freinkel studied that there was a state of accelerated starvation in 
pregnancy7 and greater than normal levels of ketonemia and ketonuria could 
hamper the normal fetal development. Therefore strict dietary manipulations 
like marked restriction of calorie intake should be avoided as it can enhance 
ketogenesis. 
PATHOGENESIS OF GESTATIONAL DIABETES MELLITUS 
In majority of the women,insulin resistance increases as pregnancy 
advances creating demand for more insulin. In the majority,the insulin 
requirements are readily met so balance between insulin resistance and supply is 
balanced. When resistance takes the upper hand due to impaired secretion of 
insulin, hyperglycemia sets in. As in non-insulin dependent diabetes mellitus 
,GDM is associated with both impaired secretion and resistance 8. The two 
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disorders share the same risk factors and have the same genetic susceptibility. 
They can be assumed to be etiologically indistinct with one preceding the other. 
INSULIN SENSITIVITY AND RESISTANCE IN PREGNANCY 
The development of resistance to the glucose lowering effects of insulin 
is normal during pregnancy. Burt 9 demonstrated that pregnant women 
experience fewer hypoglycemic events to insulin infusion when compared to 
non-gravid women.  Buchanan et al10 and Cousins 11 et al demonstrated 
significant decrease in insulin sensitivity during second trimester of normal 
pregnancy with a return to normal values shortly after delivery. Ryan et al 12 
was the first to report quantitative differences in insulin sensitivity between 
normal and diabetic pregnancies. .Kalhan et al and Cowett et al 13 noted that 
hepatic glucose production was increased in patients with GDM than in control 
groups. 
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OESTROGEN AND PROGESTRONE 
In early pregnancy maternal estrogen and progesterone increase causes 
beta cell hyperplasia and increase the secretion of insulin14. There is increase in 
peripheral glucose utilizationand glycogen storage with reduction in hepatic 
glucose production cause fasting hypoglycemia. As pregnancy advances these 
hormones lead to increased peripheral resistance in the tissues.  The anti-insulin 
activity of progesterone peaks by 32 weeks of gestation 15 
CORTISOL 
Cortisol levels increase as pregnancy advances and by the end of 
pregnancy concentrations are higher by three fold when compared to non-
pregnant women16. Excess glucocorticoid is characterized by decreased total 
tyrosine phosphorylation of insulin receptors and is related to post receptor 
mechanism causing increased insulin resistance17 
HUMAN PLACENTAL LACTOGEN 
The hormone levels increase at the beginning of second trimester. It 
brings about a decrease in phosphorylation of Insulin receptor substrate and is 
responsible for profound insulin resistance 18 
LEPTIN 
Fasting insulin and leptin concentrations correlate with the body fat 
making leptin a good marker for obesity and insulin resistance. Leptin can be 
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responsible for both central and peripheral insulin resistance. Its levels are 
significantly higher in pregnancy markedly during second and third trimesters. 
Alterations in placental leptin levels can contribute to fetal growth 
independently of maternal glucose levels. Leptin levels are elevated in GDM 
and can predict the severity of diabetes. Wiznitzer et al 19reported the umblical 
cord leptin level was an independent risk factor for fetal macrosomia in non 
diabetic pregnant women. 
TUMOUR NECROSIS FACTOR ALPHA  
It has been found to contribute to the pathogenesis of GDM as it is 
implicated in the regulation of glucose and lipid metabolism. Catalano et al 
20reported that changes in insulin sensitivity from early to late pregnancy 
paralleled the gradual increase in TNF Alpha levels. 
ADRENOMEDULLIN 
It is a peptide hormone involved in insulin regulatory system. Its amniotic 
fluid concentration was elevated in pregnant diabetic women when compared to 
the non diabetic women. 
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DECREASED BETA CELL RESPONSE 
During normal pregnancy, oral and intravenous glucose tolerance 
decreases only slightly despite the reduction in insulin sensitivity. This is due to 
gradual increase in secretion of insulin by the beta cells. This happens because 
of a combination of beta cell hyperplasia and hypertrophy 21. In GDM,the early 
insulin response to OGTT is reduced compared to non-diabetic women 
suggesting a defect in beta cell response. First phase beta cell responses to 
glucose infusion in GDM are also reduced. Women with normal beta cell 
function are at lower risk for developing diabetes 22 
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To sum up,the dominant pathogenic factor in GDM is a combination of 
insulin resistance and decreased insulin secretion. Pregnancy is associated with 
profound hormonal changes that have a direct effect on carbohydrate tolerance. 
In most subjects, pancreatic insulin secretion increases to meet this need,but in 
those with underlying beta cell dysfunction,hyperglycemia ensues. Results also 
suggest that increase in insulin receptor serine /threonine phosphorylation and 
PC-1(Plasma cell membrane glycoprotein) could underlie the insulin resistance 
of pregnancy and contribute to its pathogenesis. 
 
The metabolic and endocrine changes in the second half of gestation inducing 
physiological pregnancy related insulin resistance worsen the underlying 
metabolic disturbances leading to full blown GDM. Impaired first phase 
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secretion of insulin,increased second phase insulin release,increased hepatic 
glucose output relative to prevailing hyperinsulinemia,reduced insulinogenic 
indices,reduced glucose absorption from the gut,changes in insulin kinetics play 
an important role in the pathogenesis of GDM. 
Other metabolic changes include increased release of amylin and pro 
insulin that could be a cause or consequence of beta cell dysfunction23. 
Increased intrahepatic and intramyocellular mass and impaired flux through 
myocellular ATP synthase has also been found in patient with GDM 24. 
Impaired lipid metabolism with increased FFA concentrations is also noted. 
Impaired insulin receptor phosphorylation and insulin receptor tyrosine kinase 
activity further contribute to metabolic disturbances in GDM25. Increased 
osteoclastin levels in GDM could be regarded as compensatory mechanism to 
cope up with increased demand on insulin secretion,decreased osteopontin 
levels relate to decrease levels in GDM. 
PLACENTA IN DIABETIC PREGNANCY 
Improvements in glycemic controls in the recent yearshave led to less 
pronounced placental weight differences between normal and diabetic 
pregnancies. The occurrence of placentomegaly as a result of increased 
parenchymal tissue cellularity reflected by higher DNA contents confirms a 
close relationship of placental weight to that of the offspring26 . There is 
enlargement of villous surface by 30-50% and increase in the total capillary 
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surface area. There is increased trophoblastic membrane thickening and 
hyperplasia of the placental endothelial cells. The placental barrier function is 
altered 27 
Uteroplacental blood flow may be compromised due to 
a)inadequate opening of spiral arterioles by shallow invasion of trophoblast 
b)Narrowing of placental bed lumen because of fibrinoid necrosis and foam cell 
deposition 28 
c) Enlargement of placental villi resulting in decreased intervillous space 
volume 
d)Imbalance in prostacyclin /thromboxane production favoring thromboxane 
e) Hyperglycemia induced reduction in trophoblastic estradiol production which 
has apotent effect on uterine vasculature,hence decreased intervillous perfusion 
29 
AMNIOTIC FLUID IN GDM 
Hydramnios in GDM has been reported to be as high as 26% which is 40 
times that found in non-diabetic controls30. This can be extrapolated from 
osmotic diuresis of hyperglycemic diabetic adult to fetus the hyper glycemic 
diabetic mother. There was a significant association between amniotic fluid and 
maternal glucose concentration31. In one study, a cohort of 41 insulin treated 
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women hospitalized for glycemic control for one month underwent 
amniocentesis prior to elective delivery at 38 weeks. Compared to non-diabetic 
cohort these demonstrated higher amniotic fluid glucose levels and increased 
amniotic fluid index. These observations suggest the effect of maternal diabetes 
upon fetal urine production may require a chronic stimulus associated with 
maternal hyperglycemia. 
Reiher et al32 demonstrated positive immunohistologic staining for insulin 
in embryonic fetal pancreas at 9 weeks in pregnancy complicated by diabetes. 
The fetuses of non-diabetics do not appear to release insulin in response to 
acutely induced fetal hyperglycemia. Subsequent studies have suggested that 
prior to mid pregnancy the fetus may produce insulin in women who are at a 
high risk of subclinical glucose intolerance. Weiss found that third trimester 
samples of amniotic fluid insulin correlated with birth weights independent of 
the degree maternal glucose intolerance. 
Strangenberg et al33 found an association of amniotic C-Peptide in third 
trimester specimens with birth weight suggesting fetal insulin production / renal 
clearance as manifest in amniotic fluid concentrations are biologically more 
proximate to pathogenic processes producing diabetic fetopathy.  C-Peptide is 
released in equimolar amounts with insulin. Unlike insulin that is cleared by the 
liver and kidney, C-Peptide is cleared primarly by the kidney. Consequently 
amniotic fluid C-Peptide correlate better with fetal insulin release in the third 
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trimester in GDM pregnancies.   Arginine stimulated amniotic fluid C-Peptide 
and insulin have been associated with fetal macrosomia among insulin treated 
diabetic pregnant women34 
To sum up GDM is associated with increase amniotic fluid volume. 
Amnoitic fluid insulin and C-Peptide are primarily excreted from the fetus there 
by reflecting fetal pancreatic development in response to intrauterine 
environment. Late pregnancy amniotic fluid insulin concentrations correlate 
with the diabetic status. Late pregnancy amniotic fluid insulin and C-peptide 
levels are associated with clinical signs of diabetic fetopathy in the neonatal 
period.  
DIABETES FOLLOWING GESTATIONAL DIABETES MELLITUS 
Although glucose tolerance returns to normal in majority of GDM shortly 
after delivery,there is substantial evidence that they have an increased risk of 
developing overt diabetes mellitus in future. O Sullivan found a 36% incidence 
of diabetes in women with previous history of GDM 22-28 years after 
pregnancy 35,36,37. 
For the diagnosis of GDM, different diagnostic criteria have been 
employed. In majority of the studies GDM was  diagnosed during pregnancy. In 
the study from Aberdeen GDM was assumed to have occured based on the 
findings of an abnormal intravenous glucose tolerance test during post partum 
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period. This tends to select GDM women with relatively more profound 
metabolic aberrartions  since glucose tolerance normally improves shortly after 
pregnancy. In contest to most of the studies, O Sullivan only included GDM 
subjects with a normal glucose tolerance after pregnancy in accordance with the 
GDM definition used at that time . 
At follow up, majority of the studies applied 75g oral glucose tolerance 
test evaluated by the WHO. Not all women with GDM during a specific period 
are available for participation in a follow up examination several years later. It 
is important that the women who are investigated at follow up constitute a 
representative and a large subset of initial GDM population to ensure that the 
study material is no skewed in anyway that can affect the results. Only few 
studies give information regarding the participation rate and representativity of 
the study participants . It has been documented that GDM women with 
signifcantly increased fasting plasma glucose at diagnosis and those who are 
treated with insulin have increased risk of developing overt diabetes later in life 
than those treated with diet alone38,39 . When comparing follow up studies it is 
important to know what the treatment or the metabolic status was during the 
index pregnancy. The current GDM definition allows women with undiagnosed 
type 2 diabetes antedating pregnancy to be categorised as having GDM. Thus in 
population with high incidence of these women, a relatively high rate of 
abnormal glucose tolerance in the post partum period may be found. 
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The incidence of overt diabetes in the general population is increasing 
with age. Hence the time span between the index of pregnancy and follow up 
examination should be considered. 
In the Copenhagen study 40, all women with GDM treated with meal plan 
or insulin were followed up postpartum with a six year median observation time 
since the index of pregnancy and 34.4% of them had abnormal glucose 
tolerance  in the 2 month postpartum period out of which 13.7% developed 
diabetes. The incidence of abnormal glucose tolerance seems to increase with 
increasing follow up time since pregnancy. 
Predictive factors  for the development of overt diabetes in women with GDM : 
Having confirmed that women with GDM are at risk for subsequent 
development of overt diabetes it is important to predict who among these 
women are at highest risk. The following are the risk factors for the 
development of diabetes or abnormal glucose tolerance during and after the 
postpartum period in women with GDM. 
 Increasing maternal age 
 Maternal overweight  
 High fasting glucose at GDM diagnosis 
 Low fasting insulin at diagnosis 
 Low C- peptide during OGTT at diagnosis 
16 
 
 Insulin treatment during pregnancy 
 Poor Beta cell compensation for insulin resistance during pregnancy 
 Low gestation age at diagnosis of GDM 
The majority of GDM women who have an abnormal glucose tolerance 
during the postpartum period (although not overtly diabetic ) will 
normalise their glucose tolerance within one year 41. These women have a 
more disturbed glucose metabolism compared with women with normal 
glucose tolerance in the postpartum period and are expected to have 
increased risk of development of diabetes in later life.  
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RISK FACTORS OF GDM : 
Various risk factors have been identified for gdm and they have stratified 
to low risk, intermediate risk and high risk  (4th international workshop 
conference on GDM ) 42. They are as follows, 
Low risk (blood glucose screening not routinely required ) 
 Member of ethnic group where GDM prevalence was low 
 Age less than 25 years. 
 Negative history of diabetes in the first degree relative 
 Negative history of abnormal glucose metabolism 
 Normal weight before pregnancy 
 Normal weight at birth. 
Moderate risk ( blood glucose testing done at 24- 28 weeks  by 1 step or 2 step 
procedure) : 
 Member of ethnic group that had high prevalence of GDM 
 Age > 25 years. 
 Diabetes in the first degree relative 
 Over weight before pregnancy 
 High birth weight 
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High risk ( glucose testing at the first antenatal visit / as soon as possible ): 
 Obesity 
 Previous history of GDM 
 Previous history of impaired glucose tolerance/ glycosuria 
 Prior macrosomic baby 
 Strong family history of type 2 DM 
 
SCREENING OF GESTATIONAL DIABETES MELLITUS: 
    Screening in GDM is of utmost importance as early diagnosis can 
reduce both fetal and maternal complications. There has always been a debate 
about whether the screening should be universal or selective. The American 
diabetes association  4th international workshop on GDM advocated that 
screening should be done in all intermediate and high risk women43. Opinions 
also differ regarding screening and diagnostic techniques due to differences in 
population risks and risk benefit ratio. 
  Random blood sugars , timed sample in relation to meals , serum 
fructosamine and HbA1c are poor screening tests44. Fasting plasma glucose has 
a high false positive rate. Women who have normal fasting and postprandial 
levels of glucose might show an exaggerated response to glucose challenge.  
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TWO STEP APPROACH: 
It was recommended by the ACOG . Irrespective of the prandial state , 50 
g of anhydrous glucose was given orally. Venous blood glucose was measured 
an hour later. This is the glucose challenge test. The test was considered 
positive , if the glucose level was higher than 140mg/ dl. A positive test is 
followed by the oral glucose tolerance test ( OGTT ) 
The OGTT is done is done after an overnight fasting of 8 hours preceded 
by an unrestricted diet for 3 days ( atleast 150g carbohydrates per day and 
unlimited physical activity ). 100g anhydrous glucose solution is offered . The 
cutoffs  are the following 
Blood glucose levels Carpenter and Coustan 
criteria (in mg/dl ) 
National diabetes data 
group criteria ( in mg/dl) 
Fasting 95 105 
1 hour 180 190 
2 hour 155 165 
3 hour 140 145 
 
If two or more of the values are abnormal a diagnosis of GDM is made.  
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ONE STEP APPROACH : 
The HAPO trial 45 showed there was increased maternal and perinatal 
complications with increasing levels of glycemia even in the non diabeticrange  
or even in those sugar level ranges that were considered normal in pregnancy. 
This lead to the development of one step approach. 
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Here a 75g OGTT is done and plasma glucose levels are estimated after 1 and 2 
hours. GDM is diagnosed if any one of the 3 values are met ( IADPSG 2011)46 . 
Fasting >92mg/dl 
1 Hour >180mg /dl 
2 hour >153 mg/dl 
 
GDM SCREENING IN INDIA : 
Indians are a high risk population for the development of Diabetes with the 
well known fact India being the diabetic capital of world screening for GDM is 
of prime importance in our antenatal mothers. The DIPSI(Diabetes in pregnancy 
study group India) 47 guidelines is followed in India 
 Universal screening is followed  
 Single step procedure is followed 
 Its both screening as well as diagnostic  
 Irrespective of the prandial state, the pregnant women is given 75g 
glucose load orally and a 2hour blood glucose value is measured if the 
cut off is more than or equal to 140mg /dl she is branded to have GDM. 
The advantages are : 
 Fasting state is not required, the test can be performed at the first visit 
itself and repeated again in the successive trimesters. 
22 
 
 Both screening and diagnostic procedure 
 No interference in the daily routine of women 
The rationale behind the test is a normal glucose tolerant women is 
expected to maintain a euglycemic status despite the glucose challenge. In case 
of GDM the glycemic excursion exaggerates further . 
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FETOMATERNAL COMPLICATIONS OF GDM 
GDM causes complications in both the mother and fetus.The fetus 
experiences complications in utero as well as in the neonatal period. Long term 
complications in growth and neuro development can occur in later life and there 
is increased predisposition to metabolic X syndrome. As far as the mother is 
concerned apart from the antenatal complications,there is increased 
predisposition to development of type 2 Diabetes in later life increasing the 
morbidity. 
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MATERNAL COMPLICATIONS OF GDM 
HYPERTENSIVE DISORDERS DURING PREGNANCY: 
It has been found that women with GDM have an increased risk of 
development of preecclampsia when compared to non GDM Pregnant women. 
Preecclampsia is usually diagnosed with new onset hypertension and 
Proteinuria during 2nd half of an antenatal period. Recent ACOG Guidelines say 
that the presence of Proteinuria is not mandatory for the diagnosis of 
preecclampsia and the condition can be diagnosed even in the absence of 
Proteinuria in women who are hypertensive along with deranged liver function 
,progressive renal insufficiency, Thrombocytopenia, Pulmonary odema, new 
onset cerebral or visual disturbances.  A portion of this risk is due to coexisting 
mutual risk factors between GDM and precclampsia48 These include  obesity, 
positive family history, increased maternal age etc.  GDM per se is an 
independent risk factor for the development of precclampsia,the relative risk 
ranging from 1.4 to 2.549,50,51.   
Insulin Resistance in Preecclampsia 
Studies have shown that women with preecclampsia are more insulin 
resistant prior to pregnancy as well as in first and second trimesters and in years 
following pregnancy when compared to normotensive pregnancy.  Conditions 
associated with increased insulin resistance like GDM, obesity, polycystic ovary 
syndrome were also found to be risk factors for the development of 
hypertension during pregnancy52.  Laboratory parameters in the metabolic 
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syndrome of insulin resistance are observed more frequently in women with 
hypertension during pregnancy.  These parameters include  
 
 Hyperinsulinemia 
 Hyperlipidemia 
 Increased levels of Plasminogen activator inhibitor – 1 
 Leptin 
 Tumor Necrosis factor alpha 
Casey et al49 compare 61209 pregnant women who were nondiabetic to 874 
GDM women who were on medical nutrition therapy. It was found that there 
was an increased risk of hypertensive disorders in the GDM population (17%) 
when  compared to non diabetic  women (12%)  Joffe et al50 did the calcium for 
preecclampsia prevention trial. (CPEP) in 4598 nulliparous women.  There was 
an increased risk of preecclampsia in women with GDM the relative risk being 
1.67.   
Yogevet al51 studied 1813 GDM patients and demonstrated that 
preecclampsia is GDM patient is diagnosed at a younger age during first 
pregnancy, and in those with higher gestational weight gain. The rate of 
preecclampsia paralleled with the severity of GDM at diagnosis and also with 
the level of glycemic control. This data was strengthened by the results of 
HAPO study.   
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PLASMA GLUCOSE OF 1 SD. THE ODDS RATIO FOR 
PREECCLAMPSIA 
Fasting 1.21 (95% CI 1.13 to 1.29) 
One hour 1.28 (95% CI 1.2 to 1.7) 
Two hour 1.28 (95% CI 1.2 to 1.7) 
 
A common etiological pathway underlies both GDM and preecclampsia. 
Many maladaptations to pregnancy are present in both the conditions. These 
include 
 Endothelial dysfunction 
 Angiogenic imbalance (high SFllt-1/low PGF) 
 Increased oxidative stress (high free radicals / low antioxidant) 
 Dyslipidemia 
Chesley reported an increased risk of late onset diabetes in women with 
previous history of preecclampsia.  When considering both pregnancy 
conditions, the risk of developing diabetes is moderately increased in women in 
who had preeclampsia alone, greatly elevated in women who had GDM alone 
and highest in women who had both GDM and preeclampsia.  
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CESAREAN SECTION AND INSTRUMENTAL DELIVERIES. 
There was increased caesarean section rates and operative vaginal 
delivery in women with GDM. It was independent of the birth rate the caesarean 
section rate was approximating to 30%53.  Tri-hospital GDM study53 was 
conducted in 1996.  It studied the rate of caesarean delivery in relation to birth 
weight & glucose tolerance. Women treated with GDM, untreated borderline 
GDM  were cases and the controls were antenatal women without glucose 
28 
 
intolerance.  The results demonstrated that untreated women with borderline 
GDM had increased rate of caesarean section  (29.6%) when compared to 
controls. (29.2%). As did had women with treated GDM compared to controls. 
(odds ratio 2.1). 
Even in women treated with GDM although the birth weight was 
normalised  they remain at a higher risk of caesarean delivery of about 33%.  
This suggest that diagnosis of GDM lowers threshold for intervention by 
caesarean delivery independent of birth weight. The risk is increased nor only 
for caesarean deliveries but also for operative vaginal deliveries.  Compared 
with nondiabetic women with GDM are more prone  to the risk of Operative 
Vaginal Delivery. This risk was significantly increased by the degree of glucose 
intolerance  (FPG  > 105 mg/dl.) and maternal weight. Factors associated with 
the higher incidence of caesarean section in GDM include  
 Age above 30 years 
 Occurrence of prior caesarean deliveries 
 Fetal macrosomia 
 Cephalopelvic disproportion 
 Unfavourable cervix for induction 
 Fetal distress 
 Risk of intrauterine death 
 Gestational age < 37 weeks or > 40 more weeks  
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POLYHYDRAMNIOS 
 
 
 
Polyhydramnios is defined as pathological  increase of amniotic fluid 
volume in pregnancy.  It is diagnosed ultrasonographically when amniotic fluid 
index (AFI) > 25 cms. Or when single vertical pocket is > 8 cms. It can be due 
to various causes, common most include fetal anomalies  and gestational 
diabetes mellitus.  There exists a dynamic equilibrium between production and 
resorption of amniotic fluid. Fluid levels are influenced by fetal urination and 
fetal lung liquid production.  Polyhydramnios complicates 5 to 25% of diabetic 
pregnancy.  The various underlying mechanism includes 
 Fetal hyperglycemia causing fetal polyuria resulting in increased 
osmotic diuresis 
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 Placentomegaly increasing the surface area of the placenta leading 
to increased amniotic fluid volume 
 Associated congenital anomalies and metabolic derangements 
 
The prevalence of polyhydamnios is 18.8%.  It can be an indicator of 
diabetogenic fetopathy. The various complications of polyhyramnios include  
o maternal dyspnea 
o increased exhaustion 
o premature rupture of membrane 
o preterm labour 
o fetal malposition 
o umblical cord collapse 
o uterine atony 
o abruptioplacentae 
o abdominal discomfort due to overdistended uterus 
 
PRETERM LABOUR 
It is defined as delivery before 37 weeks of gestation. It is one of the 
maternal complications of GDM.  However it is less common when compared 
to  other adverse outcome. In the  HAPO study 6.9% of the participants 
experienced preterm delivery both spontaneous and induced. Out of which 9.6% 
of infants were LGA where 8% underwent intensive neonatal care54. It was also 
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observed that preterm labour had minimal association with fasting glucose 
levels as well as maternal blood pressure. The association of pre term labour 
with GDM can be attributed to coexisting preeclampsia, placental abruption, 
recurrent urinary tract infection, polyhydramnios.  It should also be noted that 
3/4ths of preterms births are not associated with GDM and are spontaneous.  
 
URINARY TRACT  INFECTION 
Pregnancy causes hormonal and mechanical changes that increase the risk 
of urinary stasis and vesicoureteral reflux. These changes along with short 
urethra increase the frequency of urinary tract infection (UTI) in pregnant 
women. 
UTI is defined as presence of atleast 1.0 lakh organism / ml. of  urine in  
asymptomatic patients or > 100 organisms / ml. of urine with accompanying 
pyuria in symptomatics supported by a positive culture of uropathogen.  
Infections are mainly due to ascending colonisation of existing vaginal 
perineal and faecal flora.  Enlarging uterus causes urinary retention and stasis 
due to progesterone induced,  ureteral smooth muscle relaxation. Glycosuria  
and increased levels of urinary aminoacids during pregnancyt are additional 
factors that lead to UTI 55 When compared to nondiabetic women, women with 
GDM have a higher incidence of UTI (Prevalence in nondiabetic – 3 to 10%, 
GDM women 27.6%)  This UTI can be either asymptomatic bacterurea or 
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acutecystitis, less commonly  acute pyelonephritis.  Apart from anatomical and 
physiological changes in renal tract during pregnancy in GDM 
 there is suppression of immune system enhancing the 
progress of the condition. 
 Decreased antibacterial activity of urine as a result of 
dilution of inhibitory substances such as urea. 
 Defect in polymorphonuclear leukocyte function due to 
hyperglycemia and increased adhesive capacity of bladder 
epithelium  
It was found  that GDM was not a risk factor for postpartum UTI because 
there was no significant difference in the incidence of the disease in GDM 
women and normal women. 20 to40 % of pregnant bacteriuric women whether 
diabetic or not develop acute pyelonephritis during pregnancy if treatment is not 
provided.  Furthermore recurrent UTI increases the risk of preterm 
labour,chorioamnionitis, premature rupture of membranes and intrauterine and 
neonatal sepsis. 
 
INCREASED RISK OF POSTPARTUM TYPE T2DM  
Abnormal Carbohydrate tolerance following pregnancy with GDM was 
evaluated in numerous studies.  After 28 years of follow up of  the original 
cohort from O’Sullivan’s work that determined OGTT cut offs for GDM nearly 
half of the women with GDM had T2DM in later life. Kjos et al22 performed 75 
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gm. OGTT 5 to 8 weeks after delivery in 246 women with GDM and found 
19% had abnormal OGTT, out of which 10% had impaired glucose tolerance 
and 9% had T2DM. Sivaraman et al56 reported the risk of developing diabetes 
was 6.9% at 5 years. And 21.1% at 10 yrs. following initial diagnosis of 
GDM.Chodick et al found that the risk of T2DM among women with prior 
GDM was 15.7% upto 10 yrs. of follow up.  O’Sullivan consolidated available 
data and reported a large variance in the risk of postpartum T2DM ranging from 
6% to 60% when they were evaluated from 6 weeks after deliver to 10 yrs. later. 
The cumulative incidence of T2DM increased remarkably in the first five years 
of delivery and plateaued after 10 years.    
Risk factors for developing T2DM include58: 
 Ethnicity (e.g. African-American, Latino, Native American, Asian 
American, Pacific Islander) 
 High Parity 
 Age at delivery ≥ 33-35 years 
 Family history of diabetes 
 Duration of follow up after pregnancy 
 Early Diagnosis of gestational diabetes mellitus (< 22-24 weeks) 
 Testing modality for diagnosing diabetes (e.g. Oral glucose tolerance test, 
Fasting plasma glucose, Random plasma glucose or Hemoglobin A1C) 
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Severity of gestational diabetes mellitus 
 Degree of hyperglycemia in pregnancy and immediately postpartum 
 Number of abnormal Oral glucose tolerance test values 
 Total area under the diagnostic Oral glucose tolerance test 
 Level of fasting blood glucose on the Oral glucose tolerance test 
 Elevated fasting glucose level during pregnancy 
 Need for pharmacological therapy to achieve glycemic control 
Lifestyle parameters: 
 Consumption of dietary fat 
 Limited physical activity 
 Smoking 
Maternal Weight: 
 Gestational weight gain 
 Pre-pregnancy weight and Body Mass Index 
 Postpartum weight retention 
Metabolic syndrome parameters at early postpartum: 
 High-density lipoprotein cholesterol > 50mg/dL 
 Waist circumference of 88cm or higher 
35 
 
ACOG recommends postpartum in all GDM patients at 6-12 weeks after 
delivery using a 75 gm OGTT59. The screening is carried out annually for three 
years is values are normal and once in three years for the successive years 
lifelong.  
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FETAL COMPLICATIONS 
 
Gestational Diabetes  Mellitus is associated with an array fetal complications 
and the neonate is also affected in the long run.  The various complications in 
the fetus includes: 
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 Congenital Malformation 
 Unexplained Intrauterine Demise  
 Still Born  
 Increased Birth Weight  /  Macrosomia 
 Shoulder dystocia & Birth Injuries  
 Fetal Asphyxia 
 Perinatal Death 
 Neonatal Hypoglycaemia 
 Hyper Bilirubinemia 
 Transient Tachypnea 
 Hypocalcemia 
 Cardiomyopathy 
 Polycythemia  
CONGENITAL MALFORMATIONS 
                 The incidence of congenital malformations is higher in pregestational 
diabetes when compared to gestational diabetes mellitus. High risk of 
spontaneous abortion as well as malformation of the fetus occurred first 
trimester of pregnancy especially when the glycemic control was poor. The 
frequency of birth defect is 3 to five foldincreased when compared with the 
general population.   SHAEFER-Graf et al60, in a review of 4180 pregnancies 
complicated by GDM reported that congenital anomalies in the offspring 
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affected the same organ systems described in pregnancies complicated by 
IDDM – Insulin Dependent Diabetes Mellitus.  However most other reports 
have conflicting findings as GDM most commonly occurred after the period of 
organogenesis and have minimal effect on teratogenicity.  
The Swedish Health Registry Study covered 1.2 million birth between 
1997 and 2007 and identified 3864 infants were born to women pre-existing 
diabetes and 8688 infants born to women with GDM61. The total malformation 
rate in the first group was 9.5% and the second group 5.7%.  Although the risk 
of  anomalies in the GDM group is lower when compared to the pre GDM 
group,  it has a higher incidence when compared to the general population.  
Martinez-Frias et al62analysed 19577 consecutive infants with malformations 
for unknown cause and compared those born to mothers with GDM with those 
of non diabetic mothers.  Their findings indicated GDM is a significant risk 
factor for holoprosencephaly, upper / lower limb anomalies, spine anomalies, 
renal and urinary system anomalies.  However owing the heterogenous nature of 
GDM which includes previously unrecognised and newly diagnosed non Insulin 
Dependent Diabetes Mellitus they could not rule out the possibility that the 
teratogenic effect is related to latent NIDDM. Nevertheless pregnancies 
complicated by GDM should be considered at risk for congenital anomalies.   
The various factors responsible for these malformations include 
hyperglycemia which might have teratogenic effect during the organogenesis 
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period.  Free radical injury causing embryopathy and other metabolic 
derangement like deficiency of arachidonic acid and myoinositol inhibition of 
cellular uptake of dehydroascorbic acid and increased nonenzymatic 
glycosylation of embryonic proteins, abnormal levels of Trace metals and 
decreased catalyse activity.   
Unexplained Intrauterine Demise 
                 Gestational diabetes mellitus has a higher risk of facing the disaster 
of Unexplained Interauterine Demise especially during the third trimester 
towards term.  Careful monitoring of the fetal wellbeing especially as pregnancy 
reaches term is of significant importance. Antepartum fetal surveillance should 
be started at 32 weeks of gestation. Women with uncontrolled gestational 
diabetes need to be hospitalised and glycemic control should be achieved.   
GDM women on insulin are terminated at 38 weeks of gestation and are not 
allowed to reach 40 weeks as the chance of intrauterine device increases with 
advancing gestational age. The possible cause of fetal demise includes fetal 
hypoxia which could be attributed to the following reasons: 
 The glycosylated haemoglobin had decreased oxygen carrying capacity 
and causes leftward shift of haemoglobin and oxygen dissociation curve.  
 Decreased nutrient and oxygen transport to the fetus owing to placental 
villous odema and vasculopathy. 
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 Associated preeclampsia causing vaso constriction and thereby decreased 
nutrient supply.  
Rackham et al found that there was a curvilinear relationship between HbA1c 
and fetal weight and uteroplacental blood flow and  consequent fetal hypoxia.  
 Increased Birth Weight  /  Macrosomia 
 
                     Macrosomia is defined as birth weight of 4000 gm. and above 
regardless of the Gestational age63. Gestational diabetes mellitus is an 
independent risk factor for fetal macrosomia and large for gestational age 
babies.  50% of GDM pregnancies can be complicated by fetal macrosomia. 
The incidence of macrosomia in those with untreated GDM is high as 20% 
compared to only 6% in those who were appropriately treated.  The incidence of 
macrosomia was only 2% in those without diabetes.  
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                  The macrosomic fetus has thick skinfold higher body fat percentage 
increased shoulder circumference,  small head to abdomen circumference ratio 
leading to altered body shape and composition. This alteration in the body shape 
attributes to higher risk of shoulder dystocia, birth trauma, post 
partumhaemorrhage and ceasarian deliveries. Risk of PPH in macrosomia is 
doubled.  
                    Human fetal growth is influenced by multiple factors like parental 
genome placental sufficiency, meternal nutrition and lifestyle.  Pathological 
variation in birth weight is associated with changes in fetal production and 
action of insulin.  The increased body mass of the fetus in GDM results 
primarily from fetal hyper insulinemia as result of maternal hyper glycemia.  
These foetuses have Beta cell hyperplasia.  This was explained by  Professor 
Jorgen Pederson 64 in his hypothesis.  He found that maternal hyperglycemia led 
to fetal hyperglycemia which stimulated pancreatic beta cell hyperplasia in the 
fetus and led to fetal hyperinsulinemia. Insulin and insulin like growth factors 
exert an anabolic effect due to their mitogenic and antiapoptotic effects on cell 
differentiation thereby causing increase in skeletal growth and fat deposition.  
The pattern of overgrowth is complicated consisting of visceromegaly of liver, 
heart, lungs, adrenals and subcutaneous adiposity.  
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Effect of insulin like growth factor on islets. 
Gene Phenotype 
IGF2 Increased islet size 
IRS1 Increased islet cell mass 
Insulin Increased islet size 
IRS – Insulin Receptor Substrate 
IGF – Insulin like growth factor 
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The Pedersen Hypothesis has been extended.  It states that intrinsic fetal 
pancreatic beta cell hyperplasia pulls glucose across the placenta and assists in 
glycemic control of the mother. The initial increase in fetal size gives rise to 
hypoxemia and limitation in fetal oxygen availability alters differential tissue 
utilisation of glucose leading to alphaglycerophosphate synthesis in fetal 
adipocyte thereby increasing further adiposity.  Thus it can be concluded that 
optimal correction of hyperglycemia in the mother can lead to significant 
alteration in the fetal adiposity thereby preventing macrosomia and it’s related 
consequences.   
Delayed fetal lung maturity 
The diabetic pregnancy,especially poorly controlled GDM is an important 
risk factor for the development of respiratory distress syndrome. Planning of 
both therapy and delivery is very critical and crucial in improving the offspring 
outcome. Robert and Neff found that risk of RDS was six times higher in GDM 
women when compared to normal women65. Hyperglycemia and 
hyperbilirubinemia are involved in delayed pulmonary maturation which 
influences pulmonary surfactant biosynthesis. Carlson and Smith showed that 
insulin blocks cortisol action at the level of fibroblasts by decreasing the  
production of fibroblast pneumocytic factor. It also interefered with the timing 
of corticoid induced maturation in the fetus. The various tests for fetal lung 
maturity include: 
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 Shake test 
 Planimetric LS ratio 
 Stochiometric Ls ratio 
 Amniotic Fluid Phosphatidyl glycerol 
 Lamellar body count 
Strict blood glucose control is essential in pregnancy and decision 
to deliver should be made when the fetal lung maturity has been 
ascertained. 
Shoulder dystocia & Birth Injuries  
                  Shoulder dystocia is diagnosed when additional maneuvers are 
required to deliver the shoulder if traction on the fetal head does not suffice. In 
the HAPO study,shoulder dystocia was one of the least common outcomes only 
1.3% of women being affected. It increases the risk of birth trauma and can 
cause fetal asphyxia if neglected or late diagnosed. The condition occurs mainly 
in macrosomic fetus where there is increased fat on the shoulder. Increased odds 
of shoulder dystocia has been observed in women with glucose intolerance 
duting antenatal period. It is mainly due to abnormal anthropometric diameters 
like truncal obesity,large shoulder diameter as well as increased weight of the 
mother. 
            The ACHIOS trial (Australian Carbohydrate Intolerance Study in 
Pregnant women) observed whether treatment gestational diabetes reduced the 
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perinatal complications. Primary outcomes included shoulder 
dystocia,bonefracture,nerve palsy and it was found that the risk of serious 
perinatal complications were lower in infants of the intervention group when 
compared to the routine care group. A positive relationship was found between 
maternal hyperglycemia in the fasting state and the risk of shoulder dystocia.1 
mmol rise in fasting OGTT leads to a relative risk of 2.09. Dystocia occurred 
mostly in births requiring operative vaginal delivery. 
                 Brachial plexus injuries is one of the most important complication of 
this condition present in 4-16%. It was found to be independent and unrelated to 
the operator experience. Majority reolved without permanent disability while 
permanent dysfunction was seen in less then 10%.. 
PERINATAL MORTALITY 
                The perinatal mortality is increased in GDM women when compared 
to the normal population and it has a direct relationship with the stringency of 
glycemic control. This could be due to various causes like congenital anomalies, 
unexplained still births,intrapartumasphyxia,unexplained stillbirths, respiratory 
distress syndrome,neonatal sepsis etc. 
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SHORT TERM IMPLICATIONS IN THE NEONATE 
NEONATAL HYPOGLYCEMIA 
                Most dreaded complication in the neonate of the GDMmother. It is 
defined as plasma glucose concentration<40 mg % or serum glucose 
concentration <45 mg %. Codero et al66observed that neonatal hypoglycemia 
rate in GDM babies was 25%. The most accepted definition of neonatal 
hypoglycemia is the Pedersen hypothesis which has been already discussed. The 
hypothesis was further extended by Freinkel,who examined the role of other 
nutrients that provided substrate for the fetus. He introduced the concept of 
pregnancy as a “tissue culture experience”proposing that the placenta and the 
fetus develop in an incubation medium derived from maternal fuels1. As all this 
constituents are regulated by maternal insulin,any disturbance in its supply or 
action can lead to hyperinsulinemia. Other factors like defective counter 
regulation by catecholamines or glucagon lead to increased glucose tolerance 
and decreased glucose production. Early diagnosis and prompt management of 
the condition is essential to prevent late consequences of acute neurological 
injury and permanent neurological sequelae. 
NEONATAL HYPOCALCEMIA 
                 It is defined as serum calcium level <8 mg % in term infants and <7 
mg% in preterm infants. The severity of the condition is linked to the severity of 
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maternal hyperglycemia,the reported rate being 10-20% in GDM babies67. 
Hypocalcemia could be due to the following reasons: 
 Parathyroid hormone concentrations are lower in IDM than infants of non 
diabetic mothers during the first four days of life. 
 Glycosuria induced loss of maternal urinary magnesium leads to 
hypomagnesemia that inhibits PTH secretion leads to hypocalcemia. 
 Persistently high levels of Calcitonin in IDM leading to hypocalcemia 
If promptly treated it has a good prognosis even in those with 
convulsions. 
RESPIRATORY DISTRESS SYNDROME 
               It is constellation of clinical,radiological and laboratory findings due 
to deficient surfactant production leading to decreases lung compliance and 
hypoxia. Robert et al68 found a 5-6 fold rise in RDS in IDM than those of non 
diabetic mothers. The RDS incidence dropped significantly from 31% to 3% 
with introduction of strict glucose control during pregnancy and delivery at term 
or near to term. 
 Fetal hyperinsulinemia blocks normal enzyme inducing action of cortisol 
on fetal type 2 pneumocyte production of surfactant due to inhibited 
production of phosphatidyl choline and fibroblast pneumocyte factor.  
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 Insulin converts glycerol –b-phosphate to pyruvate and acetyl coA 
decreasing its availability for phospholipid synthesis69. 
 Insulin interferes with the conversion of phosphatidic acid to 
phosphatidyl glycerol which has a stabising effect on surfactant. 
As phosphatidyl glycerol signal final maturation of surfactant 
production,once it appears the infants of GDM and Pre GDM mothers can 
be delivered. If elective delivery before 38 weeks of gestation in planned 
fetal lung maturity should be ascertained.  
Other early neonatal complications include: 
 Polycythemia 
 Hyperbilirubinemia 
 Thrombocytopenia 
 Ventricular septal hypertrophy 
GROWTH AND NEURODEVELOPMENT OF CHLDREN BORN TO GDM 
MOTHERS 
              Children born to diabetic mothers are often macrosomic,especialy 
when maternal hypergylcemia occurs during the second and third trimesters. On 
follow up,themacrosomic children tend to normalise their weight and height 
within the first year of life but there is a stronger tendency for increased weight 
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gain and development of metabolic X syndrome in later life70. Children born 
SGA tend to be smaller for atleast first several years of life. 
                 If the sugars are well controlled in pregnancy,the intellectual function 
of the offspring is usualy within normal limits. However fine and gross motor 
abilities,attention span and activity levels are impaired among those born to 
GDM mothers when matched with the controls71. In some studies the 
differences compared to controls are larger in children between the ages of 5-8 
and these differences are reduced in older children. It is possible that the 
metabolic abnormalities during pregnancy delay brain maturation and therefore 
fine neurological functions are impaired at an young age. 
              These results emphasise the importance of good glycemic control 
during the antenatal period thereby preventing the diasatrous effects of these 
long term complications in their children. 
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MATERIALS AND METHODS 
STUDY DESIGN 
Prospective observational study 
PERIOD OF STUDY 
One year (October 2016-September 2017) 
Purpose of the study: 
 The prevalence of diabetes mellitus (DM) is increasing worldwide and 
more in developing countries including India.  
 As women with gestational diabetes mellitus (GDM) and their children 
are at increased risk of developing diabetes mellitus in future, special 
attention should be paid to this population especially in developing 
countries. 
 Early detection and prompt management will help to decrease the 
maternal and fetal morbidity and prevent long term complications 
All patients attending the Antenatal OPD at Chengalpattu medical college 
hospital were offered a 75g GCT. Those who had GCT values more than 
140mg/dl were included in the study.Study involves 400 patients 
diagnosed with GDM irrespective of the period of gestation. Height, 
weight, and blood pressure were measured at  everyvisit. Through proper 
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history taking, clinical examination and lab investigations glycemic 
control was achieved on medical nutrition therapy or insulin and  these 
patients  are followed up from antenatal period  till six weeks postpartum.  
Fetomaternalcomplications , perinatal outcome ,the number of patients 
developing glucose intolerance postpartum (diagnosed by 75 g 0GTT) are 
evaluated during the study period  
Inclusion criteria 
 Patients  diagnosed  with gestational diabetes mellitus (by 75g 
OGCT according to DIPSI guidelines) 
 Singleton pregnancy 
Exclusion criteria: 
 Chronic hypertension 
 Patients with pregestational diabetes mellitus 
 Patients on medications that can alter the glucose metabolism like 
steroids,antipyschotics,diuretics ,oral contraceptive pills,beta 
blockers 
 Patients with abnormal thyroid profile 
 Cushings syndrome 
 Chronic medical illness 
 Autoimmune disease 
 Multiple pregnancy 
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INVESTIGATIONS 
ANTENATAL: 
 Hemoglobin,Platelet count 
 Urine routine,urine culture sensitivity 
 Serum urea,creatinine,electrolytes 
 Liver enzymes 
 75g Oral Glucose challenge test 
 Fasting and Postprandial blood glucose 
 Ultrasonography 
POSTPARTUM: 
 75g Oral Glucose Tolerance test 
 Fasting and Postprandial blood glucose 
 
 
 
 
 
 
53 
 
PARAMETER NORMAL VALUES 
Hemoglobin 12-16 g/dl 
Urine culture sensitivity < 105  organism/ml urine 
Platelet count 1.5-4 lakhs/cu.mm 
Total Bilirubin 0.2-1 mg/dl 
Indirect Bilirubin 0.1-1.0 mg/dl 
Direct Bilirubin 0-0.2 mg/dl 
AST/SGOT 5-43 U/L 
ALT/SGPT 5-56 U/L 
LDH <400 U/L 
Serum uric acid 3-7 mg/dl 
Blood urea <20  mg/dl 
Creatinine 0.7-0.9 mg/dl 
GCT <140 mg/dl 
FBS <92 mg/dl 
PPBS <140mg/dl 
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OUTCOMES ANALYSED 
1) Primary outcome 
•     Maternal outcome-mode of delivery 
o      Fetal outcome- Birth condition 
o Birth weight 
o Birth trauma 
o Congenital anomalies 
2) Otheroutcomes 
• ANTEPARTUM COMPLICATIONS: 
o Pre eclampsia 
o Urinary tract infection 
o Preterm labour 
o Premature rupture of membranes 
 Postpartum:   Incidence of overt diabetes mellitus/glucose intolerance 
STATSTICAL ANALYSIS 
 Primary data was entered in MS Excel and analyzed using SPSS 20v. 
 The results were presented in terms of tables and graphs. 
 The descriptive statistics frequency and percentage were calculated. 
 The association between the categorical variables was analyzed by chi 
square test with 5% level of significance.     
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RESULTS AND ANALYSIS 
1. AGE DISTRIBUTION 
Age Frequency Percent 
<20years 50 12.4 
21-25 years 105 26.3 
26-30 years 131 32.7 
31-35 years 84 21.1 
36-40 years 30 7.5 
Total 400 100 
 
 
In this study,the maximum population of GDM patients came under the 
age group 26-30 years(32.7%).GDM in teenage pregnancy was encountered in 
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12.4% of the study population. The elderly gravidas covered 7.5%. In this  
study,the occurrence of GDM was lesser in the extremes of age group. The 
lower incidence in the elderly could be probably because these mothers would 
have had established pregestational diabetes and therefore did not meet the 
inclusion criteria.  
2. MODE OF DELIVERY 
Mode of Delivery Frequency Percent 
LSCS 196 49 
ELECTIVE LSCS 85 21.2 
EMERGENCY LSCS 111 27.8 
INSTRUMENTAL 20 5 
LABOUR NATURALIS 184 46 
Total 400 100 
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Majority of the study population delivered via lower segment caesarean 
section ( 49%)  out of which 21.2% had elective LSCS and 27.8 % had 
emergency LSCS. The most common indications for emergency LSCS were the 
following in order 
 Failed induction – 65.3 % 
 Meconium stained liquor – 15.2% 
 Fetal distress- 15.5% 
 Cephalopelvic disproportion in labour -14% 
The indications for elective LSCS included 
 Macrosomia 
 Repeat LSCS 
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51% of the study population delivered vaginally out of which 46%  
delivered via labournaturalis and 5 % via instrumental delivery. The most 
common indication for instrumental delivery was large baby with birth weight 
more than 3.5kg . 
Mode of Delivery Meal Plan Insulin Total Chi Sq P 
Normal 90 94 184 
29.18 0.001 
Instrumental 10 10 20 
Emergency LSCS 49 62 111 
Elective LSCS 13 72 85 
Total 162 238 400 
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It was observed that in the study population,the Caesarean section rate 
was higher in those women who were on insulin when compared to those on 
meal plan(p value=0.001) which was statisticaly significant. 
Among the 184 women who delivered via labour naturalis,94 of them 
were on insulin and 90 of them on meal plan. Equal proportion was also 
observed in the instrumental delivery(n=10 in both the groups) 
3. PARITY 
PARITY Frequency Percent 
PRIMI 175 43.8 
G2P1L1 166 41.5 
G2A1 5 1.2 
G3A2 3 0.8 
HOB 47 11.7 
G3P1L1A1 4 1 
Total 400 100 
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Out of 400 women , 175 women were primi gravida  (43.8%).  166 
women were 2nd gravidas with a previous live child (41.5%). Higher order 
births constituted 11.7 % . In these two groups 80% had prior uncomplicated 
pregnancy and 20 % had prior history of GDM, out of which 12 % had normal 
OGTT value in the post  partum period and the remaining 8 % did not turn up 
for the follow up. Women with previous history of abortion constituted 2 % and 
in most of these women the cause of previous abortion was unknown . 
 
 
Frequency Percent 
Primi 175 43.8 
Multi 225 56.2 
Total 400 100 
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4. GESTATIONAL AGE AT DIAGNOSIS 
Gestational Age Frequency Percent 
< 20 weeks 16 4 
20 – 28 weeks 34 8.5 
28 – 34 weeks 105 26.2 
34 – 36 weeks 217 54.2 
>36 weeks 28 7 
Total 400 100 
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The maximum occurrence of GDM was between 34 – 36 weeks of 
gestation (54.2%) , which can be attributed to the fact that insulin resistance was 
maximum during the last 3 months of pregnancy that was observed in the 
previous studies. 26.2 % of GDM occurred between 28 – 34 weeks of gestation. 
The occurrence was 8.5 % in gestation between 20- 28 weeks and 7 % in 
gestation age more than 36 weeks . Only 4 % of the study population were 
diagnosed with GDM at gestational age less than 20 weeks. 
5. TREATMENT PLAN 
TREATMENT Frequency Percent 
Meal Plan 162 40.5 
Insulin 238 59.5 
Total 400 100 
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In this study, 238 out of 400 women were started on insulin (59.5%) and the 
remaining 162(40.5%) women had their glycemic control achieved with meal 
plan alone.  
6. POLYHYDRAMNIOS 
POLYHYDRAMNIOS Frequency Percent 
No 330 82.5 
Yes 70 17.5 
Total 400 100 
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In this study, out of 400 women, 70 women had polyhydramnios (17.5%) 
.In these 70 women 44 women  were on insulin and 26 women were on meal 
plan, 32 % of them underwent preterm labour. Out of these 70, 38 women had 
isolated polyhydramnios and the remaining 32 had other associated maternal 
complications.  
7. PRE ECLAMPSIA: 
Pre eclampsia Frequency Percent 
Absent 296 74 
Mild 36 9 
Severe 68 17 
Total 400 100 
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Pre eclampsia was seen in 26 % of the study population ( n = 104 ). 
Severe preeclampsia was seen in 17 % ( n = 68 ) and mild pre eclampsia was 
seen in  9% ( n=36 ).  Among those who had severe preeclampsia 80% of them 
were on insulin (n=55) and the remaining 20 % were on meal plan ( n =13).  
Among those who had mild preclampsia 70 % of them were on insulin ( n-25) 
and the remaining 30 % were on meal plan ( n=11). 
Preeclampsia Meal Plan Insulin Total Chi Sq P 
Absent 138 158 296 
18.98 0.001 
Mild 11 25 36 
Severe 13 55 68 
Total 162 238 400 
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Out of the 400 GDM women 104 had pre eclampsia(36 women had 
severe pre eclampsia and 68 women had mild pre eclampsia). The incidence of 
pre eclampsia was more in those women who were treated with insulin than 
those women whose glycemic control was achieved with meal plan alone and 
the p value was statistically significant(p value=0.03 chi sq=18.98). This can be 
explained by the theory that insulin resistance also plays a role in pathogenesis 
of pre eclampsia and the two conditions share common factors contributing to 
the pathogenesis. 
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8. UTI 
UTI Frequency Percent 
No 356 89 
Yes 44 11 
Total 400 100 
 
 
44 out of 400 GDM(11%) women had urinary tract infection . Out of 
these 44 women 32 women underwent preterm labour (72 % ), giving birth to 
low weight babies. Most of UTI was seen in late half of 1st trimester and the 2nd 
trimester.  
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9. PRETERM LABOUR 
PRETERM Frequency Percent 
N0 365 91.2 
Yes 35 8.8 
Total 400 100 
 
 
In this study 8.8 % had preterm labour( n= 35) . Most of them had associated 
complications of polyhydramnios and urinary tract infection indicating that 
these could be the causative factors for the preterm birth.   
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POLYHYDRAMNIOS 
vs PRE TERM No Yes Total 
Chi 
sq 
P OR 
No 318 12 330 
61.76 0.001 1.43 Yes 47 23 70 
Total 365 35 400 
 
 
Out of the 35 women who delivered preterm 23 of them had associated 
polyhydramnios suggesting that polyhydramnios could be the cause for preterm 
labour and the results were statisticaly significant (p value=0.001 chi sq=61.76) 
and the odds ratio was >1. 
UTI vs PRE TERM No Yes Total Chi sq P OR 
No 353 3 356 
253.4 0.001 3.64 Yes 12 32 44 
Total 365 35 400 
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Out of the 35 GDM women who had preterm labour,32 of them had 
associated UTI or previous history of UTI and the p value was statistically 
significant(0.001). the odds ratio was 3.64 indicating that women with UTI had 
three times more risk of delivering preterm than those without UTI. 
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10.  PROM 
PROM Frequency Percent 
No 373 93.2 
Yes 27 6.8 
Total 400 100 
 
 
PROM was seen in 6.8 % of the study population . Out of 400 women 27 
had premature rupture of membranes( n= 27) . In these 27 women 14 of them 
underwent caesarean section ad 12 delivered via labournaturalis and 1 via 
instrumental delivery. 2 of them had preterm premature of membranes ( 
PPROM ).Clear liquor was seen in 14 women who had PROM and the liquor 
was meconium stained in the remaining 13.  
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11. FETAL OUTCOME 
Fetal Outcome Frequency Percent 
IUD 8 2 
Still Born 2 0.5 
Live Birth 380 95 
Early Neonatal Death 10 2.5 
Total 400 100 
 
 
Out of the 400 GDM pregnancies , 380 were live birth ( 95 %) . intra 
uterine death was seen in 2 % (n= 8 ). Out of these eight, 3 of them were 
preterm IUDs  and the remaining 5 were term IUDs.  
Out of the 400 pregnanices , 2 were still born ( 0.5%) and early nenonatal 
death( within 7 days ) was seen in 2.5 %.  The causes of early neonatal death in 
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order are respirtory distress syndrome ( n=5), hypoglycemia and HIE ( n=4), 
sepsis ( n=1).  Out of the 10 early neonantal death, 7 had congenital anomalies 
and the p value was statiscally significant  
12.  APGAR 
APGAR Frequency Percent 
Apgar Score 0 10 2.5 
Apgar Score <3 29 7.2 
Apgar Score >3 361 90.2 
Total 400 100 
 
 
All babies with the 10 minute APGAR less than 3 were said to have birth 
asphyxia and 29 babies ( 7.2%) had birth asphyxia with the 10 minute APGAR 
74 
 
score less than 3.  13 out of these 29 babies had congenital anomalies . Of these 
29 babies 10 expired in the early nenonatal period.  
361 babies had an 10 min APGAR score > 3 ( 90%). APGAR score of zero was 
found in 10 babies which belonged to the intra uterine death and still born 
category. 
13. BIRTH WEIGHT 
Birth Weight Frequency Percent 
<2.5 46 11.6 
2.5-3.5 186 46.5 
3.6-4 115 28.8 
>4 53 13.1 
Total 400 100 
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Most ( 46.5%) of the babies born to GDM mothers had birth weight ranging 
from 2.5 to 3.5 kg ( n =186) . 11.6 % of babies were low birth weight ( n= 46 ) . 
Of these 46 babies , 35 were preterm . 28.8 % ( n= 115 )weighed between 3.6 to 
4 kgs .  
  
Meal 
Plan Insulin Total 
Chi Sq p OR 
Nil 154 183 337 
22.64 0.001 5.78 Macrosomia 8 55 63 
Total 162 238 400 
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Macrosomia ( > 4kg ) was seen in 13.1 % of the babies ( n = 55). Of these 
babies , 48 were born to mother who were on insulin and the p value was 
statistically significant (0.001). 
 Birth trauma and shoulder dystocia was seen in 5 babies . Out of the 55 
babies who were macrosomic , 48 were delievered by LSCS, 8 via instrumental 
and 3 via labour naturalis. 
14. SHOULDER DYSTOCIA  / TRAUMA 
Shoulder Dystocia / 
Trauma Frequency Percent 
No 393 98.2 
Yes 7 1.8 
Total 400 100 
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Out of 400 pregnancies , shoulder dystocia and birth trauma was seen in 
1.8 % ( n= 7). This was encountered in large babies with birth weight ranging 
from 3.9 to 4.3 kgs.  5 babies had birth asphyxia ( 10 minute APGAR < 3), 
however these babies improved in the neonatal period and had a good neonatal 
outcome.  
Dystocia / 
Trauma Meal Plan Insulin Total 
Chi Sq P 
No 162 231 393 
4.85 0.03 Yes 0 7 7 
Total 162 238 400 
 
 
 
In this study it was observed that the most important cause for shoulder 
dystocia and birth trauma was macrosomia. Shoulder dystocia was encountered 
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mainly in babies ranging between 3.8kg-4.1 kg in birth weight.  Out of 400 
babies,7 of them had shoulder dystocia.The glycemic profile of  all these 7 
mothers were controlled with insulin and the p value was statistically 
significant(chi sq 4.85) 
15.  CONGENITAL ANOMALIES 
CONGENITAL 
ANOMALIES Frequency Percent 
No 379 94.8 
Yes 21 5.2 
Total 400 100 
 
 
The incidence of congenital anomalies was seen in 5.2 % ( 21/ 400 ) . 50 
% of these congenital anomalies occurred in early onset GDM ( n =11) , where 
the gestation age was less than 20 weeks.  
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Intra uterine death was seen in 6 babies who had congenital anomalies . 7 
anomalies babies suffered early neonatal death and 2 were still born . The 
remaining 6 babies had congenital anamoly compatible with life. The most 
common congenital anamoly encountered in order were  
 single umbilical artery  
 spina bifida,  
 septal defects 
 duodenal atresia 
GA vs ANOMALIES No Yes Total Chi sq P 
<20 WEEKS 5 11 16 
136.7 0.001 
20 -28 WEEKS 34 0 34 
28-34 WEEKS 104 1 105 
34-36 WEEKS 209 8 217 
>36 WEEKS 27 1 28 
Total 379 21 400 
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Congenital anomalies were present in 21 babies.Out of these 21 babies 11 
babies were born to mothers with early onset GDM diagnosed before 20 weeks 
of gestation  and the p value was statisticaly significant(p value=0.001 chi 
sq=136.7) 
16. POSTPARTUM FOLLOW UP 
Post Partum Frequency Percent 
Normal 287 71.8 
Elevated 91 22.8 
Loss to follow up 22 5.5 
Total 400 100 
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In the post partum follow up 400 GDM mothers the attrition rate was 5 % 
( n=22) .Of the remaining 378 women the OGTT was performed at 6 weeks 
post partum and was found to be elevated in 91 women. In these 91 women, 69 
women were on insulin and 22 women were on meal plan. The remaining 287 
women had normal OGTT values. This implied that GDM women who were 
treated on insulin were glucose intolerant in the postpartum period as well and 
the p value was statsistically significant.   
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Post Partum 
Meal 
Plan Insulin OR 
P 
Normal 131 156 
2.63 0.001 
 
Elevated 22 69 
     
 
The ODDS ratio was 2.63 indicating that GDM  women who were treated with 
insulin had twice the risk of becoming glucose intolerant than those on meal 
plan. 
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DICUSSION  
GDM has been diagnosed as a clinical entity for the past 50 years. Early 
studies have strongly indicated untreated carbohydrate intolerance during 
pregnancy is associated with higher rates of maternal mortality and morbidity. 
The purpose of screening , treatment and management of GDM is to prevent 
still birth, congenital anomalies, pre eclampsia , intra uterine death and decrease 
the incidence of macrosomic babies and cesarean section rates thereby reducing 
maternal and perinatal morbidity and mortality. The findings of the present 
study confirmed that GDM patients are liable to have adverse pregnancy 
outcomes. 
The maximum incidence of GDM occurred between 26 to 30 years of age 
( 32.7%). Ismail NA et al reported the maximum mean maternal age of GDM in 
their study was 27.9 years.  
The increasing incidence was seen in higher parity which was also 
reported by Farook et al. In this study similar findings were observed (56.2 % in 
multigravida and 43.8 % in primi gravidas).  
The maximum number of GDM cases were detected between 34 and 36 
weeks of gestation (54.2%),which  can be attributed to the fact that the 
maximum insulin resistance occurs at this age which was also reinforced by 
Peraldi et al 
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Mutummatou leidi73 et al studied that caesarean section rates was higher 
in women with GDM (52 % ). In this study, the incidence of caesarean section 
was higher (49 %) when compared to labournatura( 46%). 
Ameya R et al72 studied the feto maternal outcomes in GDM and found 
that preclampsia complicating pregnancy was found in 26 % of GDM mothers. 
In this study also, 26 % of GDM mothers had associated GDM complicating 
pregnancy. 
Mutummatouleidi et al observed increasing frequency of preterm labour 
and polyhydramnios in GDM patients. Krishnamoorthy et al studied that the 
incidence of pre eclampsia in GDM was 30 % and preterm labor and PROM 
was 9 % and 8 % respectively. In this study preterm labour was encountered in 
8.8 % of the population and PROM in 6. 8%. 
As far as the fetal complications were concerened congenital anomalies 
were encountered in 5.2% of the study population, while according to Ameya et 
al 8% had congenital anomalies. The incidence of macrosomia was 13.2% in 
this study whereas higher incidence was noted in the other studies(40% in study 
by Ameya et al and 23 % in study by Mutummatou et al). Adverse  fetal 
outcome (still born,intrauterinedeath,early neonatal death)was seen in 5% of the 
study population and birth asphyxia in 7.2%. Shoulder dystocia was seen only 
in 1.8% of the study population. 
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During the postpartum follow up at six weeks ,22.8% of the women were 
glucose intolerant and those on insulin had twice the risk of being glucose 
intolerant than those on meal plan alone.Kjos et al22 performed 75 gm. OGTT 5 
to 8 weeks after delivery in 246 women with GDM and found 19% had 
abnormal OGTT, out of which 10% had impaired glucose tolerance and 9% had 
T2DM. 16.9% of the population were glucose intolerant in the study by Ameya 
et al. 
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CONCLUSION 
To conclude,based on the observations of this study,GDM is associated 
with adverse complications in both the mother and fetus. A large proportion of 
women also progress to become overt diabetics in the future hampering with 
their quality of life by causing morbidity in various forms. Therefore all 
antenatal women attending the OPD should be offered a simple Glucose 
challenge test and if found negative  the test has to be repeated every trimester. 
Once diagnosed with GDM appropriate glycemic control either via insulin or 
meal plan has to be achieved for good pregnancy outcome and to prevent the 
complications. Proper counseling should be given to the patient at the time of 
discharge to have her sugars checked in the postpartum period.Early detection 
and prompt management of this condition can tremendously reduce the short 
term and long term complications in both the mother and neonate. 
 
 
 
 
 
 
87 
 
LIMITATIONS OF THE STUDY 
 The GDM mothers could be followed up only till six weeks postpartum 
and long term follow up was not feasible in the one year study period. 
 Postpartum follow up could not be achieved in 100% of the study 
population as few women did not turn up for follow up. 
 The cause of prior abortions or fetal loss(that could have been due to 
overt diabetes) remained uninvestigated in few patients and they were 
included in the study 
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ABBREVIATIONS 
GDM-Gestational Diabetes Mellitus 
NIDDM-Non insulin dependant Diabetes Mellitus 
IDM-Insulin dependant Diabetes Mellitus 
RDS-Respiratory distress syndrome 
ATP-Adenosine triphosphate 
T2 DM-Type 2  Diabetes Mellitus 
OGTT-Oral glucose tolerance test 
GCT-Glucose challenge test 
DIPSI-Diabetes in pregnancy study group India 
HAPO-Hyperglycemia and adverse pregnancy outcome 
IADPSG-International association of Diabetes and pregnancy study group 
ACOG-American college of Obstetricians and Gynecologists 
FFA-Free fatty acid 
Sflt-Solubefms like tyrosine kinase 
LGA-Large for gestational age 
FBS-Fasting blood sugar 
PPBS-Post prandial blood sugar 
UTI-Urinary tract infection 
PROM-Premature rupture of membranes 
PROFORMA 
Study No :      Hospital No. : 
Name :      Occupation  : 
Age  : 
Address : 
 
SOCIO- ECONOMIC STATUS: 
1. CHIEF COMPLAINTS                                         
2. HISTORY OF PRESENTING COMPLAINTS  
H/o months of amenorrhea 
Able to perceive fetal movements yes/no 
C/o pain abdomen   yes/no 
C/o leaking/bleeding PV 
C/o headache/blurring of vision/pedal edema 
C/o oliguria / epigastric pain 
c/o burning micturition yes/no 
 
3. OBSTETRIC HISTORY  
Married life    
Consanguinity   
Obstetric score: Gravida 
                           Para 
                           Living 
                           Abortion 
                           Dead 
Booked/ Unbooked 
Details of each pregnancy: 
No of 
pregnancies 
Period of 
gestation 
Associated 
complications 
Outcome 
NVD/LSCS 
Baby details 
     
 
Present pregnancy: booked at 
 Trimester history: 
 I trimester:  H/O excessive vomiting/fever/UTI 
 Folic acid supplementation 
                     Dating scan 
II trimester:  Quickening felt at 
                      Anomaly scan 
                      C/O headache/blurring of vision/pedal edema  
C/O draining/bleeding pv 
                      C/O burning micturiton 
III trimester: Perceiving fetal movement                 
                      C/O headache/pedal edema/blurring of vision   
                      C/O draining/bleeding pv 
4. MENSTRUAL HISTORY 
 Age of Menarche: 
 Flow: 
 Clots: 
 Dysmenorrhoea:  
 LMP:   Wks.   Days 
 EDD:   Wks.   Days 
5. PAST HISTORY 
DIABETES/HYPERTENSION/Connective tissue disorders/Bronchial 
asthma/cardiac disease/thyroid disorders/blood transfusion/surgery 
6. FAMILY HISTORY  
TB / Bronchial Asthma / Diabetes mellitus / Hypertension / Any cancer / 
Bleeding disorders / Thyroid disorders  
7. PERSONAL HISTORY 
Diet     :  
Appetite   :  
Bowels   : 
Micturition    :  
Sleep    : 
8. EXAMINATION OF PATIENT: 
    On examination  
1. Height in cms               : 
2.  Pre pregnant Weight : 
Present weight : 
 Weight gain  : 
BMI    : 
3. Temperature in degree 
4. BP in mm of Hg 
5. Respiratory rate per minute 
6. Pulse rate 
7. Pallor 
8. Edema 
9. Icterus  
Systemic examination 
a. CVS 
 b. RS  
c. Per abdomen : 
Inspection:  abdomen-normal/over distended 
Striaegravidarum  :  
 Linea nigra   : 
Dilated veins/sinuses : 
           Palpation:  Fundal height: 
                   Abdominal Circumference : 
 Fundal grip     :                                    
 Lateral grip      :                                      
 Pelvic grip                          :                                     
 Liquor: adequate/scanty 
Auscultation: FHS (/min) 
EFW 
Per vagina: cervix dilatation: 
Length  : 
Effacement  :  
Position  : 
Consistency  : 
Vertex station       : 
Membranes  : 
Pelvis: adequate/not: 
 
DIAGNOSIS: 
Investigations  
Hb 
RBS 
PCV  
Blood group  
Urine routine: albumin/ Sugar 
BT 
CT 
HIV  
HBsAg 
VDRL 
          Glucose challenge test 
          FBS/PPBS  
Blood urea 
Serum Creatinine 
Serum Uric acid 
 LFT 
Platelet count: 
USG  
Fetal ECHO 
Electrocardiogram 
Fundoscopy 
Treatment: Insulin/Meal Plan 
Pregnancy outcome: 
 Gestational age at delivery 
 Vaginal delivery: assisted/ spontaneous 
 Caesarean section 
 Maternal complications 
Perinatal outcome: 
 Live/Still birth/IUD 
 Congenital anomalies 
 10 min APGAR 
 Birth weight 
 Birth trauma 
 Neonatal Deaths 
POSTPARTUM OGTT- Elevated/Not elevated 
 
INFORMATION SHEET 
Place of Study                  : Chengalpattu Medical College Hospital 
Name of the Investigator: Dr. Nithya.V 
Name of the Participant :  Age:  Hospital No: 
 
We are conducting a study on “FETOMATERNAL OUTCOME OF 
GESTATIONAL DIABETES MELLITUS” The purpose of the study is to 
identify the antepartum intrapartum and postpartum complications and their 
incidence in patients with gestational diabetes mellitus and to study the outcome 
of pregnancy in these patients and the incidence of GDM patients turning to 
overt diabetics during the postpartum follow up after six weeks. 
The privacy of the patient in the research will be maintained throughout 
the study. In the event of any publication or presentation resulting from the 
research , no personally identifiable information will be shared. 
Taking part in the study is voluntary. You are free to decide whether to 
participate in this study or to withdraw at any time. Your decision will not result 
in any loss of benefits to which you are otherwise entitled. 
 The results of the special study may be intimated to you at the end of the 
study period or during the study if anything is found abnormal which may 
aid in the management or treatment. 
 You  are invited to take part in this study. The information in the document 
is meant to help you decide whether or not to take part . Please feel free to 
ask if you have any queries or concerns. 
 We have obtained approval from the institutional ethical committee 
 
PRINCIPAL INVESTIGATOR 
DR.NITHYA.V 
II year MS post graduate, 
Department of Obstetrics and Gynaecology 
Chengalpattu medical college, Chengalpattu. 
 
 
Signature of investigator                         Signature of patient /guardian 
Date : 
Chengalpattu 
 
 
 
 
 










செங்கல்படட்ு அரசு சபொது மருத்துவமனையில் மகப்பபறு மற்றும் 
மகளிர் நல துனறயில் ஆரொய்ெச்ி நனடசபற்றுவருகிை்றது. 
நீங்களும் இந்த ஆரொய்ெச்ியில் பங்பகற்க நொங்கள் 
விரும்பிகிபறொம். இதைொல் உங்களுக்கு எந்த பொதிப்பும் ஏற்படொது 
எை்பனத சதரிவித்துக் சகொள்கிபறொம். 
முடிவுகனள அல்லது கருத்துகனள சவளியிடும் பபொதுஅல்லது 
ஆரொய்ெச்ியிை் பபொது உங்களது சபயனரபயொ அல்லது 
அனடயொளங்கனளபயொ சவளியிடமொட்படொம் எை்பனதயும் 
சதரிவித்துக்சகொள்கிபறொம். 
இந்த ஆரொய்ெச்ியில் பங்பகற்பது தங்களுனடய 
விருப்பத்திை்பபரில் தொை் இருக்கிறது. பமலும்நீங்கள் 
எந்தபநரமும்இந்த ஆரொய்ெச்ியிலிருந்து  பிை்வொங்கலொம் 
எை்பனதயும் சதரிவித்துக் சகொள்கிபறொம். 
இந்த சிறப்பு பரிபெொதனைகளிை் முடிவுகனள ஆரொய்ெச்ியிை் 
முடிவிை் பபொது தங்களுக்கு அறிவிப்பபொம் எை்பனதயும் 
சதரிவித்துக் சகொள்கிபறொம். 
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MASTER CHART 
                                                                    MATERNAL COMPLICATIONS  
                                                                                                                                                                                                    
FETAL COMPLICATIONS 
S.NO NAME 
AG
E 
PARI
TY 
GEST AGE 
AT 
DIAGNOSIS               
<20 weeks-
1             20-
28 weeks-2                 
28-34 
weeks-3                
34-36 
weeks-4                  
>36 weeks-
5 
TREA
TME
NT 
POLYH
YDRA
MNIOS 
PRE 
ECLAMPSIA                           
ABSENT-1                           
MILD PRE 
ECLAMPSIA-
2                             
SEVERE PRE 
ECLAMPSIA-
3 
UTI 
PRETERM 
LABOUR 
PROM 
MODE OF 
DELIVERY 
FETAL 
OUTCOME                    
IUD-1                    
STILL BORN-2                              
LIVE BIRTH-3                               
EARLY 
NEONATAL 
DEATH-4 
BIRTH
WEIGHT
APGAR                      
SCORE 0-
1                  
10 MIN 
APGAR<3
-2                     
10MIN 
APGAR>3
-3 
SHOULDE
R 
DYSTOCI
A AND 
BIRTH 
TRAUMA 
AN
O
M
ALI
ES 
POSTPARTUM 
6 WEEKS 
OGTT                                      
NORMAL-1                                   
ELEVATED-2                                          
LOSS TO 
FOLLOW UP-3 
1 JEMIMA 18 
PRIM
I 
3 
MEA
L 
PLAN 
NO 1 NO NO NO 
INSTRUME
NTAL 
3 3 3 NO NO 1 
2 ARULMARY 23 G2A1 3 
MEA
L 
PLAN 
NO 1 NO NO NO 
LABOUR 
NATURA 
3 2.4 3 NO NO 1 
3 RADHA 31 
G3P2
L2 
4 
INSU
LIN 
NO 1 NO NO NO 
ELECTIVE 
LSCS 
3 2.75 3 NO NO 1 
4 PRIYA 25 
PRIM
I 
1 
MEA
L 
PLAN 
NO 1 NO NO NO 
LABOUR 
NATURA 
3 4 2 NO 
YE
S 
3 
5 KAMATCHI 19 
PRIM
I 
4 
MEA
L 
PLAN 
NO 1 NO NO NO 
LABOUR 
NATURA 
3 3 3 NO NO 1 
6 
SARGUNA
M 
23 
PRIM
I 
3 
INSU
LIN 
YES 1 
YE
S 
YES NO 
LABOUR 
NATURA 
3 2.4 3 NO NO 1 
7 KANCHANA 28 
G2P1
L1 
3 
MEA
L 
PLAN 
NO 3 NO NO NO 
ELECTIVE 
LSCS 
3 2.6 3 NO NO 1 
8 RASIKA 36 
G3P2
L2 
2 
INSU
LIN 
YES 2 
YE
S 
YES NO 
LABOUR 
NATURA 
3 2.3 3 NO NO 2 
9 PREETHI 23 
PRIM
I 
1 
INSU
LIN 
NO 3 NO NO NO 
ELECTIVE 
LSCS 
4 4.2 2 NO 
YE
S 
1 
10 VIMALA 25 G3A2 5 
INSU
LIN 
NO 1 NO NO NO 
ELECTIVE 
LSCS 
3 3.6 3 NO NO 1 
11 ANITHA 20 
PRIM
I 
4 
MEA
L 
PLAN 
NO 2 NO NO NO 
INSTRUME
NTAL 
3 3 3 NO NO 1 
12 KAVITHA 26 
G2P1
L1 
3 
INSU
LIN 
NO 2 NO NO NO 
LABOUR 
NATURA 
3 2.75 3 NO NO 1 
13 MEENA 26 
G2P1
L1 
3 
MEA
L 
PLAN 
NO 1 NO NO NO 
ELECTIVE 
LSCS 
3 4.2 3 NO NO 1 
14 LATHA 18 
PRIM
I 
3 
MEA
L 
PLAN 
NO 1 NO NO NO 
LABOUR 
NATURA 
1 3.6 1 NO NO 1 
15 PRIYA 30 
G3P1
L1A1 
2 
INSU
LIN 
NO 3 NO NO NO 
EMERGENC
Y LSCS 
3 2.9 3 NO NO 2 
16 YEMHA 31 
G2P1
L1 
2 
MEA
L 
PLAN 
YES 1 
YE
S 
YES NO 
LABOUR 
NATURA 
3 2.4 3 NO NO 2 
17 VASANTHA 36 
G3P2
L2 
5 
INSU
LIN 
YES 1 NO NO NO 
LABOUR 
NATURA 
3 2.75 2 NO NO 3 
18 KAVIYA 23 
PRIM
I 
2 
MEA
L 
PLAN 
YES 2 
YE
S 
YES NO 
LABOUR 
NATURA 
3 2.2 3 NO NO 1 
19 SAISKALA 25 G2A1 1 
MEA
L 
PLAN 
NO 1 NO NO NO 
LABOUR 
NATURA 
1 3 1 NO 
YE
S 
1 
20 RAMYA 18 
PRIM
I 
2 
INSU
LIN 
YES 2 
YE
S 
YES NO 
LABOUR 
NATURA 
3 2.3 3 NO NO 1 
21 JILLY 35 
G3P2
L2 
2 
INSU
LIN 
NO 3 NO NO NO 
EMERGENC
Y LSCS 
3 2.6 3 NO NO 2 
22 POONAM 26 
G2P1
L1 
3 
MEA
L 
PLAN 
NO 1 NO NO NO 
LABOUR 
NATURA 
3 3 3 NO NO 1 
23 SWETHA 32 
PRIM
I 
4 
INSU
LIN 
YES 1 NO NO NO 
EMERGENC
Y LSCS 
3 4.3 3 NO NO 1 
24 VARSHA 28 
G2P1
L1 
3 
MEA
L 
PLAN 
YES 1 NO YES NO 
LABOUR 
NATURA 
3 2.3 2 NO NO 2 
25 QUEEN 30 
G2P1
L1 
2 
INSU
LIN 
NO 1 NO NO YES 
LABOUR 
NATURA 
3 3.6 3 NO NO 2 
26 BINA 33 
PRIM
I 
4 
MEA
L 
PLAN 
NO 1 NO NO NO 
LABOUR 
NATURA 
3 2.75 3 NO NO 2 
27 UMA 26 
G2P1
L1 
5 
INSU
LIN 
NO 2 NO NO NO 
ELECTIVE 
LSCS 
3 4.5 2 NO NO 1 
28 SANKARI 18 
PRIM
I 
3 
MEA
L 
PLAN 
YES 1 
YE
S 
YES NO 
LABOUR 
NATURA 
1 2.3 1 NO NO 1 
29 MEENA 24 G3A2 1 
INSU
LIN 
NO 1 NO NO NO 
EMERGENC
Y LSCS 
3 2.6 3 NO NO 1 
30 SARANYA 28 
G3P2
L2 
3 
MEA
L 
PLAN 
YES 2 NO NO NO 
LABOUR 
NATURA 
3 3 3 NO NO 1 
31 SHANTHI 31 
PRIM
I 
2 
INSU
LIN 
NO 3 NO NO NO 
LABOUR 
NATURA 
3 3.9 3 NO NO 2 
32 SARALA 23 
PRIM
I 
2 
MEA
L 
PLAN 
YES 1 
YE
S 
YES NO 
LABOUR 
NATURA 
3 2.3 3 NO NO 1 
33 NIRMALA 33 
G2P1
L1 
2 
INSU
LIN 
YES 1 NO NO NO 
ELECTIVE 
LSCS 
3 2.7 3 NO NO 2 
34 SANTHIYA 19 
PRIM
I 
4 
MEA
L 
PLAN 
NO 1 NO NO YES 
LABOUR 
NATURA 
3 2.4 3 NO NO 1 
35 REVATHI 28 
PRIM
I 
2 
INSU
LIN 
NO 1 NO NO NO 
LABOUR 
NATURA 
3 3.9 3 NO NO 1 
36 RATHIGA 25 
G2P1
L1 
3 
MEA
L 
PLAN 
YES 1 NO NO NO 
EMERGENC
Y LSCS 
3 3 3 NO NO 1 
37 YAMUNA 31 
PRIM
I 
5 
INSU
LIN 
NO 1 NO NO NO 
LABOUR 
NATURA 
3 2.75 3 NO NO 1 
38 SUNGAVI 26 
G2P1
L1 
2 
INSU
LIN 
YES 2 NO NO NO 
ELECTIVE 
LSCS 
3 3 3 NO NO 1 
39 
SHANTHI 
PRIYA 
36 
G3P2
L2 
2 
INSU
LIN 
NO 1 
YE
S 
YES NO 
LABOUR 
NATURA 
3 2.2 3 NO NO 2 
40 
THENMOZH
I 
30 
G2P1
L1 
3 
MEA
L 
PLAN 
NO 1 
YE
S 
YES NO 
LABOUR 
NATURA 
3 2.4 3 NO NO 1 
41 VASANTHI 35 
G3P2
L2 
2 
INSU
LIN 
NO 1 NO NO NO 
ELECTIVE 
LSCS 
3 3.6 3 NO NO 1 
42 DEVI 20 
PRIM
I 
4 
INSU
LIN 
NO 1 NO NO NO 
LABOUR 
NATURA 
3 2.6 3 NO NO 1 
43 KANCHANA 26 
G2P1
L1 
3 
MEA
L 
PLAN 
YES 1 NO NO NO 
EMERGENC
Y LSCS 
3 2.75 3 NO NO 1 
44 
KALAIYARA
SI 
24 
PRIM
I 
2 
INSU
LIN 
YES 1 NO NO NO 
EMERGENC
Y LSCS 
3 2.8 3 NO NO 1 
45 
MOHANOP
RIYA 
37 
G2P1
L1 
4 
INSU
LIN 
YES 1 NO NO NO 
EMERGENC
Y LSCS 
3 3.5 3 NO NO 2 
46 SURYA DEVI 30 
G2P1
L1 
3 
MEA
L 
PLAN 
NO 1 
YE
S 
YES NO 
LABOUR 
NATURA 
3 2.2 3 NO NO 1 
47 SARANYA 23 
PRIM
I 
4 
INSU
LIN 
NO 1 NO NO NO 
LABOUR 
NATURA 
3 2.4 3 NO NO 1 
48 KALAIVANI 19 
PRIM
I 
3 
MEA
L 
PLAN 
NO 1 NO NO NO 
EMERGENC
Y LSCS 
3 3.7 3 NO NO 1 
49 MEENA  26 
G2P1
L1 
4 
INSU
LIN 
YES 3 NO NO NO 
LABOUR 
NATURA 
3 2.75 3 NO NO 2 
50 LAKSHMI 33 
G3P2
L2 
5 
INSU
LIN 
YES 1 NO NO NO 
ELECTIVE 
LSCS 
3 2.6 3 NO NO 1 
51 SARALA 28 
G3P1
L1A1 
3 
MEA
L 
PLAN 
NO 1 NO NO NO 
INSTRUME
NTAL 
3 4 3 NO NO 2 
52 
SURYA 
KANDHI 
25 
PRIM
I 
2 
INSU
LIN 
YES 3 
YE
S 
YES YES 
LABOUR 
NATURA 
3 2.2 3 NO NO 1 
53 LAILA 18 G2A1 3 
MEA
L 
PLAN 
NO 1 NO NO NO 
LABOUR 
NATURA 
3 2.9 3 NO NO 1 
54 VANITHA 24 
PRIM
I 
1 
MEA
L 
PLAN 
YES 1 NO NO NO 
EMERGENC
Y LSCS 
2 2.9 1 NO 
YE
S 
1 
55 
SURYA 
KALA 
33 
G2P1
L1 
4 
INSU
LIN 
YES 2 NO NO NO 
LABOUR 
NATURA 
3 3.7 3 NO NO 2 
56 
MANO 
PRIYA 
30 
G2P1
L1 
3 
MEA
L 
PLAN 
NO 1 NO NO NO 
LABOUR 
NATURA 
3 2.4 3 NO NO 1 
57 SIVASHINI 28 
PRIM
I 
4 
INSU
LIN 
NO 1 NO NO NO 
LABOUR 
NATURA 
3 3.7 3 NO NO 3 
58 SAINDEVI 36 
G3P1
L1A1 
3 
INSU
LIN 
YES 3 NO YES NO 
LABOUR 
NATURA 
3 2.4 3 NO NO 2 
59 LAILA 26 
PRIM
I 
3 
MEA
L 
PLAN 
YES 1 NO NO NO 
LABOUR 
NATURA 
3 2.7 3 NO NO 1 
60 
REVATHI 
SREE 
35 G2A1 5 
INSU
LIN 
YES 3 NO NO YES 
EMERGENC
Y LSCS 
3 3.7 3 NO NO 2 
61 GOMATHI 31 
G2P1
L1 
3 
INSU
LIN 
NO 1 NO NO NO 
ELECTIVE 
LSCS 
3 4.4 2 NO NO 1 
62 SEELA 30 
G3P2
L2 
4 
MEA
L 
PLAN 
NO 1 NO NO NO 
LABOUR 
NATURA 
4 2.8 2 NO NO 2 
63 LAKSHMI 20 
PRIM
I 
3 
INSU
LIN 
NO 1 NO NO NO 
EMERGENC
Y LSCS 
3 3.8 3 NO NO 1 
64 
KANAGAVA
THI 
26 
G2P1
L1 
2 
INSU
LIN 
YES 1 NO NO NO 
ELECTIVE 
LSCS 
3 2.5 3 NO NO 2 
65 
SURYAGAN
DHI 
32 G2A1 4 
MEA
L 
PLAN 
NO 1 NO NO NO 
LABOUR 
NATURA 
3 2.4 3 NO NO 1 
66 ARASI 26 
G2P1
L1 
3 
INSU
LIN 
NO 1 NO NO NO 
EMERGENC
Y LSCS 
3 3.5 3 NO NO 1 
67 MAYIL 33 
G2P1
L1 
4 
MEA
L 
PLAN 
NO 1 NO NO NO 
ELECTIVE 
LSCS 
3 2.6 3 NO NO 1 
68 PRITIKA 23 
PRIM
I 
1 
INSU
LIN 
YES 1 NO NO YES 
LABOUR 
NATURA 
3 2.4 2 NO 
YE
S 
1 
69 YAMINI 37 
PRIM
I 
3 
MEA
L 
PLAN 
NO 1 NO NO NO 
EMERGENC
Y LSCS 
4 3.8 2 NO NO 1 
70 SUDHA 26 
G3P1
L1A1 
3 
INSU
LIN 
NO 1 NO NO NO 
ELECTIVE 
LSCS 
3 4.3 3 NO NO 2 
71 CHITHRA 24 
PRIM
I 
4 
MEA
L 
PLAN 
NO 1 NO NO NO 
LABOUR 
NATURA 
3 3.9 3 NO NO 1 
72 GAJAVALLI 26 
PRIM
I 
3 
MEA
L 
PLAN 
NO 1 NO NO NO 
ELECTIVE 
LSCS 
3 3 3 NO NO 1 
73 MALAR 18 
PRIM
I 
1 
INSU
LIN 
YES 3 
YE
S 
YES NO 
LABOUR 
NATURA 
2 2.4 1 NO 
YE
S 
1 
74 AMMU 25 
PRIM
I 
4 
MEA
L 
PLAN 
NO 1 
YE
S 
NO YES 
EMERGENC
Y LSCS 
3 3 3 NO NO 1 
75 NIVETHA 33 
G3P2
L2 
3 
INSU
LIN 
YES 1 NO NO NO 
LABOUR 
NATURA 
3 2.3 3 NO NO 2 
76 
PERIYANAY
AKI 
26 
PRIM
I 
4 
MEA
L 
PLAN 
NO 1 NO NO NO 
LABOUR 
NATURA 
3 2.9 3 NO NO 1 
77 
THENAMBA
L 
28 
PRIM
I 
3 
INSU
LIN 
NO 1 NO NO NO 
ELECTIVE 
LSCS 
3 4.3 3 NO NO 2 
78 KANAMA 35 G3A2 2 
INSU
LIN 
YES 3 NO NO NO 
ELECTIVE 
LSCS 
3 2.6 3 NO NO 2 
79 DILLIRANI 36 
G2P1
L1 
5 
INSU
LIN 
NO 1 NO NO NO 
ELECTIVE 
LSCS 
3 4.5 3 NO NO 1 
80 
MANONMA
NI 
24 
PRIM
I 
3 
MEA
L 
PLAN 
NO 1 NO NO NO 
LABOUR 
NATURA 
3 3.6 2 NO NO 1 
81 SRIPRIYA 19 
PRIM
I 
4 
MEA
L 
PLAN 
NO 1 NO NO NO 
EMERGENC
Y LSCS 
3 3.5 3 NO NO 1 
82 LAVANYA 27 
G3P2
L2 
3 
INSU
LIN 
NO 1 NO NO NO 
LABOUR 
NATURA 
3 3.1 3 NO NO 3 
83 KAVITHA  31 
G2P1
L1 
3 
INSU
LIN 
NO 3 NO NO NO 
ELECTIVE 
LSCS 
3 2.9 3 NO NO 1 
84 MALINI 26 
PRIM
I 
4 
INSU
LIN 
NO 3 NO NO NO 
LABOUR 
NATURA 
3 3.8 3 NO NO 1 
85 MANJULA 24 
PRIM
I 
3 
MEA
L 
PLAN 
NO 1 NO NO NO 
EMERGENC
Y LSCS 
3 2.6 3 NO NO 1 
86 SAMITHRA 33 
G3P2
L2 
4 
INSU
LIN 
NO 3 NO NO NO 
EMERGENC
Y LSCS 
3 3 3 NO NO 2 
87 KANAGA 23 
G2P1
L1 
3 
MEA
L 
PLAN 
NO 1 NO NO NO 
LABOUR 
NATURA 
3 3.5 3 NO NO 1 
88 KARPAGAM 28 
PRIM
I 
3 
INSU
LIN 
NO 1 NO NO NO 
ELECTIVE 
LSCS 
3 4.2 2 NO NO 1 
89 THAMARAI 18 
PRIM
I 
3 
MEA
L 
PLAN 
NO 1 NO NO YES 
EMERGENC
Y LSCS 
3 3 3 NO NO 1 
90 NANTHINI 25 
PRIM
I 
5 
INSU
LIN 
YES 1 NO NO NO 
LABOUR 
NATURA 
3 2.4 2 NO NO 1 
91 VAIDEGI 32 
G3P2
L2 
2 
INSU
LIN 
YES 3 
YE
S 
YES NO 
LABOUR 
NATURA 
3 2.3 3 NO NO 2 
92 
MUNIYAM
MAL 
22 
PRIM
I 
4 
MEA
L 
PLAN 
NO 1 NO NO NO 
ELECTIVE 
LSCS 
3 3.6 3 NO NO 1 
93 
KASIYAMM
AL 
21 
PRIM
I 
1 
MEA
L 
PLAN 
YES 1 
YE
S 
YES NO 
LABOUR 
NATURA 
1 2.2 1 NO 
YE
S 
1 
94 SHOBANA 20 
PRIM
I 
3 
INSU
LIN 
NO 1 NO NO NO 
LABOUR 
NATURA 
3 3.2 3 NO NO 3 
95 ANISHIYA 24 
G2P1
L1 
3 
MEA
L 
PLAN 
YES 1 NO NO YES 
EMERGENC
Y LSCS 
3 3 3 NO NO 2 
96 SRI DEVI 26 
PRIM
I 
4 
INSU
LIN 
NO 3 NO NO NO 
INSTRUME
NTAL 
3 4 2 YES NO 2 
97 MAYA 35 
G2P1
L1 
3 
MEA
L 
PLAN 
NO 1 NO NO NO 
LABOUR 
NATURA 
3 2.6 3 NO NO 1 
98 SUSILI 31 
G2P1
L1 
4 
MEA
L 
PLAN 
NO 1 NO NO NO 
EMERGENC
Y LSCS 
3 2.75 3 NO NO 1 
99 DEVI KALA 24 
PRIM
I 
3 
INSU
LIN 
NO 3 NO NO NO 
LABOUR 
NATURA 
3 3.7 3 NO NO 2 
100 SWATHI 28 
G2P1
L1 
1 
MEA
L 
PLAN 
YES 1 
YE
S 
YES NO 
LABOUR 
NATURA 
1 2.3 1 NO 
YE
S 
1 
101 AMALA 23 
PRIM
I 
5 
INSU
LIN 
NO 1 NO NO NO 
LABOUR 
NATURA 
3 2.8 3 NO NO 1 
102 SUILA 19 
PRIM
I 
4 
MEA
L 
PLAN 
NO 1 NO NO NO 
LABOUR 
NATURA 
3 3 3 NO NO 1 
103 MEENA 27 
G2P1
L1 
3 
INSU
LIN 
NO 1 NO NO NO 
EMERGENC
Y LSCS 
3 4.2 3 NO NO 2 
104 CHITHRA 33 
G3P2
L2 
4 
INSU
LIN 
NO 3 NO NO NO 
LABOUR 
NATURA 
3 3.9 3 NO NO 2 
105 
AMBIGA 
AMMAL 
26 
PRIM
I 
3 
MEA
L 
PLAN 
YES 1 NO NO NO 
LABOUR 
NATURA 
3 2.6 3 NO NO 1 
106 PRIYA SREE 36 
G2P1
L1 
1 
INSU
LIN 
NO 1 NO NO NO 
LABOUR 
NATURA 
4 3.2 2 NO 
YE
S 
2 
107 SREEWATHI 28 
G2P1
L1 
3 
INSU
LIN 
NO 1 NO NO YES 
EMERGENC
Y LSCS 
3 4.3 3 NO NO 1 
108 
SANGEETH
A 
24 
G2P1
L1 
4 
MEA
L 
PLAN 
NO 1 NO NO NO 
LABOUR 
NATURA 
3 2.8 3 NO NO 1 
109 
DANALAKS
HMI 
18 
PRIM
I 
3 
MEA
L 
PLAN 
NO 1 NO NO NO 
LABOUR 
NATURA 
4 3 2 NO NO 1 
110 KOKILA 22 
PRIM
I 
4 
INSU
LIN 
YES 3 NO NO NO 
EMERGENC
Y LSCS 
3 2.9 3 NO NO 1 
111 PURNIMA 25 
PRIM
I 
3 
MEA
L 
PLAN 
NO 1 NO NO NO 
LABOUR 
NATURA 
3 2.75 3 NO NO 1 
112 RAGINI 32 
G2P1
L1 
4 
INSU
LIN 
NO 1 NO NO NO 
LABOUR 
NATURA 
3 3.5 3 NO NO 2 
113 
SULOCHAN
A 
26 
G2P1
L1 
3 
MEA
L 
PLAN 
NO 1 NO NO NO 
LABOUR 
NATURA 
3 2.6 3 NO NO 2 
114 
SANGEETH
A 
35 
G3P2
L2 
4 
INSU
LIN 
YES 1 NO NO NO 
ELECTIVE 
LSCS 
3 3.8 3 NO NO 1 
115 BOOMIKA 24 
PRIM
I 
5 
INSU
LIN 
NO 3 NO NO NO 
INSTRUME
NTAL 
3 4.1 2 YES NO 1 
116 KILIYAMA 31 
G2P1
L1 
3 
INSU
LIN 
NO 1 NO NO NO 
LABOUR 
NATURA 
3 3.1 3 NO NO 2 
117 POOJA 23 
PRIM
I 
4 
MEA
L 
PLAN 
NO 1 NO NO NO 
EMERGENC
Y LSCS 
3 4 3 NO NO 1 
118 BARANI 30 
G2P1
L1 
3 
INSU
LIN 
NO 1 NO NO YES 
EMERGENC
Y LSCS 
3 2.9 3 NO NO 1 
119 AMMAN 33 
G2P1
L1 
1 
MEA
L 
PLAN 
NO 1 NO NO NO 
LABOUR 
NATURA 
3 3.4 3 NO NO 2 
120 
PACHAYAM
AL 
30 
G2P1
L1 
3 
INSU
LIN 
YES 1 NO NO NO 
EMERGENC
Y LSCS 
3 2.8 3 NO NO 1 
121 
GOBINDAM
AL 
36 
G2P1
L1 
4 
INSU
LIN 
NO 2 NO NO NO 
LABOUR 
NATURA 
3 3.6 3 NO NO 2 
122 LAXMISRI 26 
PRIM
I 
3 
MEA
L 
PLAN 
NO 1 NO NO NO 
EMERGENC
Y LSCS 
3 3 3 NO NO 1 
123 JANANI 28 
PRIM
I 
3 
MEA
L 
PLAN 
NO 1 
YE
S 
YES NO 
LABOUR 
NATURA 
3 2.2 3 NO NO 2 
124 ANUPAMA 24 
PRIM
I 
4 
MEA
L 
PLAN 
NO 1 NO NO NO 
LABOUR 
NATURA 
3 3.5 3 NO NO 1 
125 MERCY 30 
G3P2
L2 
3 
INSU
LIN 
YES 3 NO NO NO 
ELECTIVE 
LSCS 
3 2.6 3 NO NO 1 
126 USHA 20 
PRIM
I 
4 
INSU
LIN 
NO 1 NO NO NO 
LABOUR 
NATURA 
3 2.9 3 NO NO 1 
127 AMMU 30 
G2P1
L1 
3 
MEA
L 
PLAN 
NO 2 NO NO NO 
LABOUR 
NATURA 
3 2.7 3 NO NO 2 
128 
SATHIYA 
PRIYA 
32 
G2P1
L1 
3 
INSU
LIN 
YES 1 
YE
S 
YES NO 
LABOUR 
NATURA 
3 2.2 3 NO NO 1 
129 SATHIYA 30 
G2P1
L1 
4 
INSU
LIN 
NO 1 NO NO NO 
ELECTIVE 
LSCS 
3 3 3 NO NO 1 
130 MERSHI 19 
PRIM
I 
3 
INSU
LIN 
NO 1 NO NO NO 
LABOUR 
NATURA 
3 2.75 3 NO NO 1 
131 RUBHA 26 
G2P1
L1 
4 
MEA
L 
PLAN 
NO 1 NO NO YES 
EMERGENC
Y LSCS 
3 3.4 3 NO NO 2 
132 
KANNAMM
AL 
33 
G2P1
L1 
1 
INSU
LIN 
YES 3 NO NO NO 
LABOUR 
NATURA 
3 2.8 3 NO NO 2 
133 FARTHIMA 24 
PRIM
I 
3 
MEA
L 
PLAN 
NO 1 NO NO NO 
INSTRUME
NTAL 
3 4.3 3 NO NO 1 
134 
YAMUNA 
DEVI 
18 
PRIM
I 
4 
INSU
LIN 
NO 1 NO NO NO 
EMERGENC
Y LSCS 
3 3.2 3 NO NO 1 
135 SEELA 25 
G2P1
L1 
4 
MEA
L 
PLAN 
NO 2 NO NO NO 
LABOUR 
NATURA 
3 3.5 3 NO NO 1 
136 KANMANI 40 
G2P1
L1 
1 
INSU
LIN 
NO 3 NO NO NO 
EMERGENC
Y LSCS 
3 2.8 2 NO 
YE
S 
2 
137 
VIJAYA 
SHANTHI 
30 
G2P1
L1 
2 
INSU
LIN 
NO 1 NO  NO NO 
LABOUR 
NATURA 
3 3 3 NO NO 2 
138 DIVYA 31 
G2P1
L1 
3 
MEA
L 
PLAN 
NO 1 NO  NO NO 
ELECTIVE 
LSCS 
3 3.6 3 NO NO 2 
139 RANCHANI 24 
PRIM
I 
4 
MEA
L 
PLAN 
YES 1 NO  NO NO 
LABOUR 
NATURA 
3 3.1 3 NO NO 3 
140 SASIKALA 35 
G2P1
L1 
4 
INSU
LIN 
NO 1 NO  NO NO 
ELECTIVE 
LSCS 
3 4.2 3 NO NO 1 
141 
MUGAMPI
GAI 
23 
G2P1
L1 
3 
INSU
LIN 
NO 1 NO  NO NO 
LABOUR 
NATURA 
3 3.7 3 NO NO 1 
142 
BHAGIYALA
KSHMI 
20 
G2P1
L1 
4 
MEA
L 
PLAN 
NO 1 NO  NO NO 
EMERGENC
Y LSCS 
3 2.9 3 NO NO 1 
143 ANANTHI 30 
G3P2
L2 
3 
INSU
LIN 
NO 1 NO  NO NO 
LABOUR 
NATURA 
3 2.8 3 NO NO 1 
144 
AMBIGA 
DEVI 
28 
PRIM
I 
4 
MEA
L 
PLAN 
YES 1 NO  NO YES 
EMERGENC
Y LSCS 
3 3.2 3 NO NO 2 
145 ANU PRIYA 33 
G2P1
L1 
3 
INSU
LIN 
NO 1 NO  NO NO 
INSTRUME
NTAL 
3 4.2 3 NO NO 1 
146 ANUTHA 26 
PRIM
I 
3 
MEA
L 
PLAN 
NO 1 NO  NO NO 
LABOUR 
NATURA 
3 3.7 3 NO NO 3 
147 RANI 37 
G2P1
L1 
5 
INSU
LIN 
NO 1 NO  NO NO 
ELECTIVE 
LSCS 
3 4.3 3 NO NO 2 
148 SUMITHRA 30 
G2P1
L1 
4 
MEA
L 
PLAN 
NO 2 NO  NO YES 
EMERGENC
Y LSCS 
3 2.6 3 NO NO 1 
149 DEVI 24 
PRIM
I 
4 
MEA
L 
PLAN 
NO 1 NO  NO NO 
LABOUR 
NATURA 
3 2.4 3 NO NO 1 
150 
SWATHA 
SREE 
30 
G2P1
L1 
4 
INSU
LIN 
NO 1 NO  NO NO 
LABOUR 
NATURA 
3 4.1 2 YES NO 1 
151 KALAIVANI 31 
G2P1
L1 
3 
MEA
L 
PLAN 
NO 1 NO  NO NO 
EMERGENC
Y LSCS 
3 2.75 3 NO NO 1 
152 MANJULA  30 
G2P1
L1 
1 
MEA
L 
PLAN 
YES 1 NO  NO NO 
INSTRUME
NTAL 
4 2.8 2 NO 
YE
S 
1 
153 
MUNIYAM
MAL 
35 
G2P1
L1 
4 
INSU
LIN 
NO 1 
YE
S 
 NO NO 
LABOUR 
NATURA 
3 3 3 NO NO 2 
154 KANNAGI 18 
G2P1
L1 
4 
MEA
L 
PLAN 
NO 1 NO  NO NO 
ELECTIVE 
LSCS 
3 2.7 3 NO NO 1 
155 
GOGULA 
PIRYA 
30 
G2P1
L1 
4 
MEA
L 
PLAN 
NO 1 NO  NO NO 
LABOUR 
NATURA 
3 3.5 3 NO NO 2 
156 SANKARI 23 
PRIM
I 
4 
MEA
L 
PLAN 
NO 1 NO  NO NO 
EMERGENC
Y LSCS 
3 2.8 3 NO NO 1 
157 SANMATHI 32 
PRIM
I 
3 
MEA
L 
PLAN 
YES 1 
YE
S 
YES NO 
LABOUR 
NATURA 
3 2 3 NO NO 1 
158 RUDHRA 24 
G2P1
L1 
1 
INSU
LIN 
NO 1 NO  NO YES 
EMERGENC
Y LSCS 
3 3.6 3 NO NO 1 
159 
THENMOZH
I 
28 
PRIM
I 
4 
MEA
L 
PLAN 
NO 1 NO  NO NO 
LABOUR 
NATURA 
3 2.9 3 NO NO 1 
160 YAMUNA 31 
G2P1
L1 
5 
INSU
LIN 
YES 1 NO  NO NO 
LABOUR 
NATURA 
3 3 3 NO NO 2 
161 MALATHI 26 
PRIM
I 
4 
INSU
LIN 
NO 1 NO  NO NO 
ELECTIVE 
LSCS 
3 4.2 3 NO NO 2 
162 
RAJAKUMA
RI 
25 
G2P1
L1 
4 
MEA
L 
PLAN 
NO 2 NO  NO NO 
LABOUR 
NATURA 
3 3 3 NO NO 1 
163 
MAHALASH
MI 
20 
G2P1
L1 
4 
INSU
LIN 
NO 1 NO  NO NO 
LABOUR 
NATURA 
4 3.4 2 NO 
YE
S 
3 
164 KAMATCHI 30 
G3P2
L2 
4 
MEA
L 
PLAN 
YES 1 NO  NO NO 
EMERGENC
Y LSCS 
3 3.2 3 NO NO 2 
165 KAYALVIZHI 33 
G2P1
L1 
4 
INSU
LIN 
NO 2 NO  NO NO 
ELECTIVE 
LSCS 
3 2.5 3 NO NO 2 
166 OVIYA 19 
PRIM
I 
1 
MEA
L 
PLAN 
NO 1 
YE
S 
YES NO 
LABOUR 
NATURA 
3 2.3 3 NO NO 1 
167 
NEELAMBA
RI 
30 
G2P1
L1 
4 
MEA
L 
PLAN 
YES 1 NO  NO NO 
LABOUR 
NATURA 
3 3.6 3 NO NO 1 
168 SONAM 24 
PRIM
I 
4 
INSU
LIN 
NO 1 NO  NO NO 
EMERGENC
Y LSCS 
3 4.3 3 NO NO 1 
169 RAHINI 30 
G2P1
L1 
4 
INSU
LIN 
NO 1 NO  NO YES 
LABOUR 
NATURA 
3 3.4 3 NO NO 2 
170 
KANNIYAM
AL 
20 
PRIM
I 
4 
MEA
L 
PLAN 
NO 1 NO  NO NO 
LABOUR 
NATURA 
3 2.9 3 NO NO 1 
171 
KRISHNAVE
NI 
26 
PRIM
I 
4 
MEA
L 
PLAN 
NO 3 NO  NO NO 
EMERGENC
Y LSCS 
3 3.2 3 NO NO 1 
172 ARTHI 28 
G2P1
L1 
3 
INSU
LIN 
YES 1 
YE
S 
YES NO 
LABOUR 
NATURA 
3 2.3 3 NO NO 2 
173 DEEPA 31 
G3P2
L2 
2 
INSU
LIN 
NO 2 NO  NO NO 
ELECTIVE 
LSCS 
3 2.75 3 NO NO 2 
174 JAYA 28 
PRIM
I 
4 
INSU
LIN 
NO 3 NO  NO NO 
ELECTIVE 
LSCS 
3 3 3 NO NO 1 
175 TARA 30 
G2P1
L1 
4 
INSU
LIN 
NO 1 NO  NO NO 
LABOUR 
NATURA 
3 3.2 3 NO NO 1 
176 
DHANUSHG
A 
20 
PRIM
I 
3 
MEA
L 
PLAN 
NO 1 NO  NO NO 
LABOUR 
NATURA 
3 3.4 3 NO NO 1 
177 BHARATHI 24 
G2P1
L1 
4 
INSU
LIN 
NO 1 
YE
S 
 NO NO 
EMERGENC
Y LSCS 
3 4.2 3 NO NO 2 
178 KAVERI 33 
G2P1
L1 
4 
INSU
LIN 
NO 3 NO  NO NO 
EMERGENC
Y LSCS 
3 3.2 3 NO NO 2 
179 KANIMOZHI 32 
G2P1
L1 
4 
MEA
L 
PLAN 
NO 1 NO  NO NO 
LABOUR 
NATURA 
3 3.1 3 NO NO 2 
180 
DIVA 
DHARSANI 
25 
G2P1
L1 
4 
INSU
LIN 
NO 2 NO  NO NO 
EMERGENC
Y LSCS 
3 3.4 3 NO NO 2 
181 GEETHA 23 
G2P1
L1 
3 
MEA
L 
PLAN 
NO 1 
YE
S 
YES NO 
LABOUR 
NATURA 
3 2.3 3 NO NO 1 
182 SELAM 28 
G3P2
L2 
2 
INSU
LIN 
NO 1 NO  NO NO 
ELECTIVE 
LSCS 
3 4.3 3 NO NO 1 
183 VANI 20 
PRIM
I 
5 
INSU
LIN 
YES 2 NO  NO YES 
LABOUR 
NATURA 
3 3.2 3 NO NO 1 
184 
GOWTHAM
I 
31 
G2P1
L1 
4 
MEA
L 
PLAN 
NO 3 NO  NO NO 
LABOUR 
NATURA 
3 3.7 3 NO NO 1 
185 KUMARI 22 
PRIM
I 
4 
INSU
LIN 
NO 1 NO  NO NO 
INSTRUME
NTAL 
3 4.1 3 NO NO 2 
186 PORKODI 33 
G2P1
L1 
2 
MEA
L 
PLAN 
YES 1 
YE
S 
YES NO 
LABOUR 
NATURA 
3 2.3 3 NO NO 1 
187 KAMACHI 26 
PRIM
I 
2 
INSU
LIN 
YES 3 NO  NO NO 
ELECTIVE 
LSCS 
3 4.2 3 NO NO 2 
188 KEERTHIKA 37 
G2P1
L1 
4 
MEA
L 
PLAN 
NO 1 NO  NO NO 
EMERGENC
Y LSCS 
3 3.2 3 NO NO 1 
189 KARTHIGA 35 
G3P2
L2 
3 
INSU
LIN 
NO 3 NO  NO NO 
ELECTIVE 
LSCS 
3 2.75 3 NO NO 1 
190 KURUPA 24 
PRIM
I 
4 
MEA
L 
PLAN 
NO 1 NO  NO NO 
LABOUR 
NATURA 
3 3 3 NO NO 3 
191 LAVANYA 39 
G3P2
L2 
3 
INSU
LIN 
NO 1 N0  NO NO 
EMERGENC
Y LSCS 
3 4.2 3 NO NO 2 
192 KODIYTHA 21 
G2P1
L1 
4 
MEA
L 
PLAN 
NO 1 NO  NO NO 
LABOUR 
NATURA 
3 3.5 3 NO NO 1 
193 
VALRMATH
I 
26 
G2P1
L1 
4 
INSU
LIN 
NO 3 NO  NO NO 
EMERGENC
Y LSCS 
3 3.2 3 NO NO 2 
194 NATHIYA 20 
PRIM
I 
4 
MEA
L 
PLAN 
NO 1 NO  NO NO 
LABOUR 
NATURA 
3 2.9 3 NO NO 1 
195 SUGANYA 28 
G2P1
L1 
4 
INSU
LIN 
YES 3 NO  NO NO 
ELECTIVE 
LSCS 
3 2.9 3 NO NO 2 
196 SAMBAVI 27 
PRIM
I 
4 
MEA
L 
PLAN 
NO 1 NO  NO NO 
LABOUR 
NATURA 
3 2.9 3 NO NO 2 
197 
MANIMEGA
LAI 
31 
G2P1
L1 
5 
INSU
LIN 
NO 2 N0  NO NO 
ELECTIVE 
LSCS 
3 2.8 3 NO NO 1 
198 
KALIYAMM
AL 
21 
PRIM
I 
4 
MEA
L 
PLAN 
NO 1 NO  NO NO 
LABOUR 
NATURA 
3 3.4 3 NO NO 1 
199 BHUVANA 32 
G2P1
L1 
3 
MEA
L 
PLAN 
NO 3 
YE
S 
YES NO 
LABOUR 
NATURA 
3 2.3 3 NO NO 3 
200 
SANTHANA
M 
27 
G2P1
L1 
4 
INSU
LIN 
YES 1 NO  NO NO 
EMERGENC
Y LSCS 
3 3.6 3 NO NO 2 
201 
PUVIYARAS
HI 
20 
PRIM
I 
4 
MEA
L 
PLAN 
NO 1 NO  NO NO 
LABOUR 
NATURA 
3 3.5 3 NO NO 1 
202 PANCHALAI 24 
G2P1
L1 
3 
INSU
LIN 
NO 3 NO  NO NO 
EMERGENC
Y LSCS 
3 2.75 3 NO NO 2 
203 TAMILISAI 23 
G2P1
L1 
4 
MEA
L 
PLAN 
NO 1 NO  NO NO 
LABOUR 
NATURA 
3 2.7 3 NO NO 1 
204 THULASI 33 
G3P2
L2 
4 
INSU
LIN 
NO 1 NO  NO NO 
ELECTIVE 
LSCS 
3 4.4 3 NO NO 1 
205 
BHUNESHW
ARI 
25 
PRIM
I 
4 
MEA
L 
PLAN 
NO 1 NO  NO NO 
INSTRUME
NTAL 
3 3 3 NO NO 2 
206 SUMITHA 28 
G3P2
L2 
2 
INSU
LIN 
NO 3 NO NO NO 
LABOUR 
NATURA 
3 3.4 3 NO NO 2 
207 SARANYA 31 
G2P1
L1 
4 
MEA
L 
PLAN 
NO 1 NO NO NO 
EMERGENC
Y LSCS 
3 2.9 3 NO NO 2 
208 DEVI 28 
G3P2
L2 
4 
INSU
LIN 
NO 1 NO NO NO 
ELECTIVE 
LSCS 
3 4.3 3 NO NO 1 
209 PRIYANGA 30 
G2P1
L1 
3 
INSU
LIN 
NO 3 NO NO NO 
LABOUR 
NATURA 
3 3.6 3 NO NO 2 
210 
MUNIYAM
MAL 
20 
PRIM
I 
4 
INSU
LIN 
NO 1 NO NO NO 
EMERGENC
Y LSCS 
3 2.7 3 NO NO 1 
211 NILA 26 
PRIM
I 
4 
INSU
LIN 
NO 1 NO NO YES 
LABOUR 
NATURA 
3 3.9 3 NO NO 1 
212 SINDEVI 34 
G2P1
L1 
5 
INSU
LIN 
NO 1 NO NO NO 
ELECTIVE 
LSCS 
3 2.75 3 NO NO 2 
213 DIYA 28 
PRIM
I 
4 
INSU
LIN 
NO 3 NO NO NO 
LABOUR 
NATURA 
3 2.8 3 NO NO 2 
214 NATHIYA 19 
PRIM
I 
4 
MEA
L 
PLAN 
NO 1 NO NO NO 
EMERGENC
Y LSCS 
3 3.7 3 NO NO 1 
215 SARANYA 28 
G2P1
L1 
3 
INSU
LIN 
NO 1 NO NO NO 
ELECTIVE 
LSCS 
3 4.1 3 NO NO 1 
216 KALAVATHI 24 
G2P1
L1 
4 
INSU
LIN 
NO 1 
YE
S 
NO NO 
ELECTIVE 
LSCS 
3 3.4 3 NO NO 1 
217 
SARAN 
GEETHA 
20 
PRIM
I 
4 
MEA
L 
PLAN 
NO 1 NO NO NO 
LABOUR 
NATURA 
3 2.7 3 NO NO 3 
218 
 DEVIGA 
SREE 
25 
PRIM
I 
4 
INSU
LIN 
NO 1 NO NO NO 
EMERGENC
Y LSCS 
3 4.3 3 NO NO 1 
219 
LEETHA 
WATHI 
30 
G2P1
L1 
3 
INSU
LIN 
YES 3 NO NO YES 
EMERGENC
Y LSCS 
3 2.6 3 NO NO 2 
220 JOHNSHI 32 
G2P1
L1 
4 
MEA
L 
PLAN 
NO 1 NO NO NO 
LABOUR 
NATURA 
3 3 3 NO NO 1 
221 SHANIYA 30 
G2P1
L1 
4 
MEA
L 
PLAN 
NO 1 NO NO NO 
LABOUR 
NATURA 
3 2.8 3 NO NO 1 
222 SANKARI 35 
G2P1
L1 
4 
INSU
LIN 
NO 3 NO NO NO 
ELECTIVE 
LSCS 
3 4.1 3 NO NO 1 
223 MEENA 26 
PRIM
I 
4 
MEA
L 
PLAN 
NO 1 NO NO NO 
INSTRUME
NTAL 
3 2.7 3 NO NO 1 
224 
SIVA 
SHANKARI 
20 
PRIM
I 
2 
INSU
LIN 
YES 2 
YE
S 
YES NO 
LABOUR 
NATURA 
3 2.3 3 NO NO 1 
225 RAMANI 28 
PRIM
I 
4 
MEA
L 
PLAN 
NO 1 NO NO NO 
ELECTIVE 
LSCS 
3 2.7 3 NO NO 1 
226 
JAYA 
SUDHA 
31 
G2P1
L1 
4 
INSU
LIN 
NO 2 NO NO NO 
ELECTIVE 
LSCS 
3 4.3 3 NO NO 1 
227 
THILAGAVA
THI 
24 
PRIM
I 
3 
INSU
LIN 
NO 1 NO NO NO 
EMERGENC
Y LSCS 
3 3 3 NO NO 1 
228 
MUNIYAM
MAL 
39 
G2P1
L1 
4 
INSU
LIN 
NO 1 NO NO NO 
ELECTIVE 
LSCS 
3 3.4 3 NO NO 2 
229 
GOVINDHA
MMAL 
30 
G3P2
L2 
4 
INSU
LIN 
NO 1 NO NO NO 
LABOUR 
NATURA 
3 3.2 3 NO NO 1 
230 RENUGA 24 
G2P1
L1 
4 
MEA
L 
PLAN 
NO 1 NO NO NO 
EMERGENC
Y LSCS 
3 2.9 3 NO NO 1 
231 ILLAVATHI 20 
PRIM
I 
4 
INSU
LIN 
NO 1 NO NO NO 
LABOUR 
NATURA 
3 3.5 3 NO NO 1 
232 
RANGANAY
AGI 
24 
PRIM
I 
4 
INSU
LIN 
YES 3 NO NO YES 
EMERGENC
Y LSCS 
3 3.2 3 NO NO 1 
233 YASODHA 23 
PRIM
I 
4 
INSU
LIN 
NO 1 NO NO NO 
LABOUR 
NATURA 
3 3 3 NO NO 1 
234 GANGA 34 
G2P1
L1 
4 
INSU
LIN 
NO 2 NO NO NO 
ELECTIVE 
LSCS 
3 4.2 3 NO NO 1 
235 PRITHEE 30 
PRIM
I 
4 
MEA
L 
PLAN 
NO 1 NO NO NO 
ELECTIVE 
LSCS 
3 3.1 3 NO NO 1 
236 MULLAI 40 
PRIM
I 
3 
INSU
LIN 
NO 3 
YE
S 
YES NO 
LABOUR 
NATURA 
3 2.4 3 NO NO 1 
237 MAITHILI 30 
G3P2
L2 
4 
INSU
LIN 
NO 1 NO NO NO 
ELECTIVE 
LSCS 
3 3.9 3 NO NO 3 
238 SUMATHI 37 
G2P1
L1 
3 
INSU
LIN 
NO 1 NO NO NO 
EMERGENC
Y LSCS 
3 3.4 3 NO NO 1 
239 RAJI 28 
PRIM
I 
4 
MEA
L 
PLAN 
NO 1 NO NO NO 
LABOUR 
NATURA 
3 3.6 3 NO NO 1 
240 ESTHAR 25 
PRIM
I 
4 
INSU
LIN 
NO 1 NO NO NO 
EMERGENC
Y LSCS 
3 4.2 3 NO NO 3 
241 
VIJAYALAKS
HMI 
32 
G2P1
L1 
4 
INSU
LIN 
NO 3 NO NO NO 
ELECTIVE 
LSCS 
3 3.8 3 NO NO 1 
242 JAYANTHI 26 
PRIM
I 
2 
INSU
LIN 
NO 1 NO NO NO 
LABOUR 
NATURA 
3 3.4 3 NO NO 1 
243 URVASHI 19 
G2P1
L1 
4 
MEA
L 
PLAN 
NO 1 
YE
S 
NO NO 
ELECTIVE 
LSCS 
3 3.9 3 NO NO 1 
244 RATHI 30 
PRIM
I 
4 
INSU
LIN 
NO 1 NO NO NO 
EMERGENC
Y LSCS 
3 3.8 3 NO NO 1 
245 SANGAVI 24 
G2P1
L1 
4 
INSU
LIN 
NO 1 NO NO NO 
LABOUR 
NATURA 
3 3 3 NO NO 1 
246 
THIVANAYA
GI 
31 
G2P1
L1 
3 
MEA
L 
PLAN 
NO 1 NO NO NO 
EMERGENC
Y LSCS 
3 3.7 3 NO NO 2 
247 MALANI 26 
G3P2
L2 
5 
INSU
LIN 
NO 1 NO NO NO 
LABOUR 
NATURA 
4 3.4 2 NO 
YE
S 
1 
248 
RAJALAKSH
MI 
30 
G2P1
L1 
3 
INSU
LIN 
NO 2 NO NO NO 
EMERGENC
Y LSCS 
3 4.3 3 NO NO 1 
249 
MANJU 
PIRYA 
20 
PRIM
I 
4 
MEA
L 
PLAN 
YES 1 NO NO NO 
LABOUR 
NATURA 
3 3.6 3 NO NO 1 
250 SHINDU 30 
G2P1
L1 
4 
INSU
LIN 
NO 1 NO NO NO 
ELECTIVE 
LSCS 
3 4.1 3 NO NO 1 
251 PREMA 24 
PRIM
I 
4 
MEA
L 
PLAN 
NO 3 NO NO NO 
LABOUR 
NATURA 
3 3.5 3 NO NO 1 
252 SREE DEVI 23 
PRIM
I 
4 
INSU
LIN 
NO 1 NO NO NO 
EMERGENC
Y LSCS 
3 3.7 3 NO NO 1 
253 RUBINI 34 
G2P1
L1 
4 
MEA
L 
PLAN 
NO 1 NO NO YES 
LABOUR 
NATURA 
3 3.9 3 NO NO 1 
254 INDRA 25 
PRIM
I 
4 
INSU
LIN 
NO 3 NO NO NO 
ELECTIVE 
LSCS 
3 3.6 3 NO NO 1 
255 JAYANTHI 24 
PRIM
I 
4 
MEA
L 
PLAN 
NO 1 NO NO NO 
LABOUR 
NATURA 
3 3 3 NO NO 1 
256 REKHA 39 
G3P2
L2 
4 
INSU
LIN 
NO 1 NO NO NO 
ELECTIVE 
LSCS 
3 4.3 3 NO NO 2 
257 RUBINI 30 
G3P2
L2 
3 
INSU
LIN 
NO 1 NO NO NO 
ELECTIVE 
LSCS 
3 3.7 3 NO NO 1 
258 PAVITHRA 24 
PRIM
I 
4 
MEA
L 
PLAN 
NO 1 NO NO NO 
INSTRUME
NTAL 
3 3.8 3 NO NO 1 
259 MARIYA 35 
G2P1
L1 
4 
INSU
LIN 
NO 3 NO NO NO 
LABOUR 
NATURA 
3 3.4 3 NO NO 2 
260 DEVAKI 30 
G2P1
L1 
2 
MEA
L 
PLAN 
NO 1 NO NO NO 
EMERGENC
Y LSCS 
3 2.9 3 NO NO 1 
261 KANMANI 34 
PRIM
I 
4 
INSU
LIN 
NO 1 NO NO NO 
LABOUR 
NATURA 
3 3.9 3 YES NO 1 
262 GOMATHI 26 
PRIM
I 
4 
INSU
LIN 
NO 2 NO NO NO 
EMERGENC
Y LSCS 
3 4.2 2 NO 
YE
S 
1 
263 UJALA 20 
PRIM
I 
3 
MEA
L 
PLAN 
NO 1 NO NO NO 
LABOUR 
NATURA 
3 3.8 3 NO NO 1 
264 
KASIYAMM
AL 
30 
G2P1
L1 
4 
INSU
LIN 
NO 3 NO NO NO 
ELECTIVE 
LSCS 
3 3.7 3 NO NO 1 
265 JERENA 24 
G2P1
L1 
5 
INSU
LIN 
NO 1 NO NO NO 
LABOUR 
NATURA 
3 4 3 NO NO 1 
266 BABY 31 
G3P2
L2 
4 
MEA
L 
PLAN 
NO 3 NO NO NO 
LABOUR 
NATURA 
3 3.6 3 NO NO 1 
267 EGATHA 28 
G2P1
L1 
4 
INSU
LIN 
NO 1 NO NO NO 
ELECTIVE 
LSCS 
3 4.3 3 NO NO 1 
268 RAMYA 30 
PRIM
I 
3 
INSU
LIN 
NO 1 NO NO NO 
ELECTIVE 
LSCS 
1 3 1 NO 
YE
S 
1 
269 TANUSRI 32 
G2P1
L1 
4 
INSU
LIN 
NO 1 NO NO NO 
LABOUR 
NATURA 
3 3.4 3 NO NO 1 
270 ILAVENI 24 
PRIM
I 
4 
INSU
LIN 
NO 3 NO NO NO 
INSTRUME
NTAL 
3 4.2 3 NO NO 3 
271 PREETHA 25 
PRIM
I 
4 
INSU
LIN 
NO 1 
YE
S 
NO NO 
LABOUR 
NATURA 
3 3.2 3 NO NO 1 
272 AISWARYA 37 
G2P1
L1 
4 
MEA
L 
PLAN 
NO 1 NO NO NO 
EMERGENC
Y LSCS 
3 3.5 3 NO NO 2 
273 
SANGEETH
A 
27 
PRIM
I 
4 
INSU
LIN 
NO 1 NO NO NO 
LABOUR 
NATURA 
3 2.4 3 NO NO 1 
274 JIJI 35 
G2P1
L1 
4 
INSU
LIN 
NO 1 NO NO NO 
EMERGENC
Y LSCS 
3 3.2 3 NO NO 1 
275 HARITHA 24 
PRIM
I 
5 
INSU
LIN 
NO 1 NO NO NO 
LABOUR 
NATURA 
3 3.7 3 NO NO 1 
276 KALYANI 26 
PRIM
I 
4 
MEA
L 
PLAN 
NO 1 NO NO NO 
ELECTIVE 
LSCS 
3 3.2 3 NO NO 1 
277 SHINY 34 
G4P3
L3 
3 
INSU
LIN 
YES 2 
YE
S 
YES NO 
LABOUR 
NATURA 
3 2.2 3 NO NO 1 
278 
SAMYUKTH
A 
28 
G3P2
L2 
3 
INSU
LIN 
NO 1 NO NO NO 
LABOUR 
NATURA 
3 3.2 3 NO NO 1 
279 ZARINA 19 
PRIM
I 
4 
INSU
LIN 
NO 1 NO NO NO 
EMERGENC
Y LSCS 
3 3.2 3 NO NO 1 
280 MEENAL 23 
PRIM
I 
4 
MEA
L 
PLAN 
NO 1 NO NO NO 
EMERGENC
Y LSCS 
3 3.2 3 NO NO 1 
281 MONISHA 32 
PRIM
I 
3 
INSU
LIN 
NO 1 NO NO NO 
LABOUR 
NATURA 
3 3.4 3 NO NO 2 
282 SUAMTHY 26 
PRIM
I 
4 
INSU
LIN 
NO 1 NO NO NO 
EMERGENC
Y LSCS 
3 3 3 NO NO 1 
283 LATHA 40 
PRIM
I 
4 
INSU
LIN 
NO 3 NO NO NO 
ELECTIVE 
LSCS 
3 3.2 3 NO NO 1 
284 INDIRA 39 
G4P3
L3 
2 
INSU
LIN 
NO 1 
YE
S 
YES NO 
LABOUR 
NATURA 
3 2.2 3 NO NO 1 
285 
RAJESHWA
RI 
24 
G2P1
L1 
3 
INSU
LIN 
NO 1 NO NO NO 
ELECTIVE 
LSCS 
3 3.2 3 NO NO 1 
286 BINU 31 
G3P2
L2 
3 
INSU
LIN 
YES 3 
YE
S 
YES NO 
LABOUR 
NATURA 
3 2.3 3 NO NO 1 
287 SANKARI 28 
G2P1
L1 
5 
INSU
LIN 
NO 1 NO NO NO 
LABOUR 
NATURA 
3 2.4 3 NO NO 1 
288 AMALA 25 
PRIM
I 
4 
INSU
LIN 
NO 1 NO NO NO 
INSTRUME
NTAL 
3 4.2 3 NO NO 3 
289 HARINI 26 
PRIM
I 
4 
MEA
L 
PLAN 
NO 3 NO NO NO 
LABOUR 
NATURA 
3 3.6 3 NO NO 1 
290 VAIDEHI 20 
PRIM
I 
4 
INSU
LIN 
NO 1 NO NO NO 
EMERGENC
Y LSCS 
3 4.3 3 NO NO 1 
291 STELLA 30 
G2P1
L1 
4 
INSU
LIN 
NO 3 NO NO NO 
ELECTIVE 
LSCS 
3 3.2 3 NO NO 1 
292 MEERA 24 
PRIM
I 
4 
MEA
L 
PLAN 
NO 1 NO NO NO 
LABOUR 
NATURA 
3 3.4 3 NO NO 3 
293 RUDRA 34 
G2P1
L1 
4 
INSU
LIN 
NO 1 NO NO NO 
ELECTIVE 
LSCS 
3 4.2 3 NO NO 1 
294 ELIZABETH 19 
PRIM
I 
3 
MEA
L 
PLAN 
NO 1 NO NO NO 
LABOUR 
NATURA 
3 3.2 3 NO NO 1 
295 RANJANI 30 
G2P1
L1 
4 
MEA
L 
PLAN 
NO 1 NO NO NO 
EMERGENC
Y LSCS 
3 3.7 3 NO NO 1 
296 KAVYA 28 
G4P3
L3 
4 
INSU
LIN 
NO 1 NO NO NO 
EMERGENC
Y LSCS 
3 3.4 3 NO NO 1 
297 KIRUBA 20 
PRIM
I 
5 
INSU
LIN 
NO 1 NO NO NO 
LABOUR 
NATURA 
3 3.2 3 NO NO 2 
298 LALITHA 26 
G2P1
L1 
4 
MEA
L 
PLAN 
NO 1 NO NO NO 
EMERGENC
Y LSCS 
3 2.9 3 NO NO 1 
299 AMBIGA 26 
PRIM
I 
3 
INSU
LIN 
NO 2 NO NO NO 
ELECTIVE 
LSCS 
3 4.4 3 NO NO 1 
300 AMMU 32 
G2P1
L1 
4 
MEA
L 
PLAN 
NO 3 NO NO NO 
LABOUR 
NATURA 
3 3.6 3 NO NO 1 
301 KARPAGAM 30 
PRIM
I 
4 
INSU
LIN 
NO 1 NO NO NO 
LABOUR 
NATURA 
3 3.2 3 NO NO 1 
302 GAYATHRI 24 
PRIM
I 
4 
MEA
L 
PLAN 
NO 1 NO NO NO 
EMERGENC
Y LSCS 
3 3.4 3 NO NO 1 
303 RENUKA 40 
G2P1
L1 
2 
INSU
LIN 
NO 1 NO NO NO 
LABOUR 
NATURA 
3 3.8 3 NO NO 1 
304 
SOUNDARY
A 
26 
G2P1
L1 
4 
INSU
LIN 
YES 1 
YE
S 
NO YES 
EMERGENC
Y LSCS 
4 4.3 2 NO 
YE
S 
2 
305 SHAJINI 19 
PRIM
I 
4 
MEA
L 
PLAN 
NO 1 NO NO NO 
LABOUR 
NATURA 
3 3.4 3 NO NO 1 
306 SHAHINA 25 
PRIM
I 
4 
INSU
LIN 
NO 1 NO NO NO 
INSTRUME
NTAL 
3 4.2 2 YES NO 1 
307 KUSHBU 30 
G2P1
L1 
4 
INSU
LIN 
NO 3 NO NO NO 
LABOUR 
NATURA 
3 3.2 3 NO NO 1 
308 ELLAMAL 39 
G2P1
L1 
3 
MEA
L 
PLAN 
NO 3 
YE
S 
YES NO 
LABOUR 
NATURA 
3 2.4 3 NO NO 1 
309 DIILIRANI 31 
G2P1
L1 
4 
INSU
LIN 
NO 1 NO NO NO 
ELECTIVE 
LSCS 
3 4.2 3 NO NO 1 
310 VINODHA 23 
PRIM
I 
3 
MEA
L 
PLAN 
NO 1 NO NO NO 
EMERGENC
Y LSCS 
3 3.4 3 NO NO 2 
311 KANCHANA 34 
G4P3
L3 
4 
INSU
LIN 
NO 1 NO NO NO 
INSTRUME
NTAL 
3 4 3 NO NO 3 
312 
MUTHAMIZ
H 
26 
G2P1
L1 
4 
INSU
LIN 
NO 1 NO NO NO 
LABOUR 
NATURA 
3 4.2 3 YES NO 1 
313 JASANTHA 28 
G2P1
L1 
4 
MEA
L 
PLAN 
NO 3 NO NO NO 
EMERGENC
Y LSCS 
3 3 3 NO NO 1 
314 JANANI 37 
PRIM
I 
3 
INSU
LIN 
NO 1 NO NO NO 
ELECTIVE 
LSCS 
3 4.2 3 NO NO 1 
315 SHEELA 23 
G2P1
L1 
4 
MEA
L 
PLAN 
NO 1 NO NO NO 
ELECTIVE 
LSCS 
3 3.4 3 NO NO 1 
316 
PRIYAMVA
DHA 
24 
G2P1
L1 
5 
INSU
LIN 
NO 3 NO NO NO 
LABOUR 
NATURA 
3 2.9 3 NO NO 1 
317 KANNAGI 32 
G2P1
L1 
2 
MEA
L 
PLAN 
NO 1 NO NO NO 
EMERGENC
Y LSCS 
3 3.7 3 NO NO 1 
318 DEVI 26 
G2P1
L1 
4 
INSU
LIN 
NO 1 NO NO NO 
EMERGENC
Y LSCS 
3 4.4 3 NO NO 1 
319 
THENMOZH
I 
25 
PRIM
I 
4 
MEA
L 
PLAN 
NO 1 NO NO NO 
LABOUR 
NATURA 
3 3.7 3 NO NO 1 
320 MALA 40 
G2P1
L1 
3 
INSU
LIN 
NO 1 NO NO NO 
ELECTIVE 
LSCS 
3 3.7 3 NO NO 2 
321 KARTHIGA 20 
PRIM
I 
4 
MEA
L 
PLAN 
NO 1 NO NO NO 
LABOUR 
NATURA 
3 3.5 3 NO NO 1 
322 MALAR 26 
G2P1
L1 
4 
INSU
LIN 
NO 1 NO NO NO 
ELECTIVE 
LSCS 
3 3.6 3 NO NO 1 
323 JANAKI 24 
G4P3
L3 
4 
MEA
L 
PLAN 
NO 3 NO NO NO 
EMERGENC
Y LSCS 
3 3.6 3 NO NO 1 
324 VATCHALA 32 
PRIM
I 
4 
INSU
LIN 
NO 3 NO NO NO 
LABOUR 
NATURA 
3 3.8 3 NO NO 2 
325 VASUKI 23 
G2P1
L1 
4 
INSU
LIN 
NO 1 NO NO NO 
EMERGENC
Y LSCS 
3 3 3 NO NO 1 
326 RAMANI 38 
G2P1
L1 
4 
INSU
LIN 
NO 1 NO NO NO 
EMERGENC
Y LSCS 
3 3.9 3 NO NO 1 
327 POORNIMA 26 
PRIM
I 
3 
MEA
L 
PLAN 
YES 3 
YE
S 
YES YES 
LABOUR 
NATURA 
3 2.4 3 NO NO 3 
328 ABIRAMI 34 
G2P1
L1 
3 
INSU
LIN 
NO 1 NO NO NO 
ELECTIVE 
LSCS 
3 3.5 3 NO NO 1 
329 SHAKTHI 26 
G2P1
L1 
4 
MEA
L 
PLAN 
NO 1 NO NO NO 
LABOUR 
NATURA 
3 3.8 3 NO NO 1 
330 
DATCHAYA
NI 
31 
PRIM
I 
5 
INSU
LIN 
NO 1 NO NO NO 
LABOUR 
NATURA 
3 4.3 2 YES NO 1 
331 BHAVANI 24 
PRIM
I 
4 
INSU
LIN 
NO 1 NO NO NO 
EMERGENC
Y LSCS 
3 3.6 3 NO NO 1 
332 KANTHA 34 
G4P3
L3 
4 
INSU
LIN 
NO 1 NO NO NO 
ELECTIVE 
LSCS 
3 3.7 3 NO NO 1 
333 HEERA 20 
G2P1
L1 
4 
MEA
L 
PLAN 
NO 1 NO NO NO 
LABOUR 
NATURA 
3 3.6 3 NO NO 1 
334 
LINGESHW
ARI 
28 
PRIM
I 
4 
INSU
LIN 
NO 3 NO NO NO 
EMERGENC
Y LSCS 
3 3 3 NO NO 1 
335 VIJYA 26 
G2P1
L1 
4 
INSU
LIN 
NO 1 NO NO NO 
INSTRUME
NTAL 
3 4.1 3 NO NO 3 
336 DHARANI 23 
PRIM
I 
4 
INSU
LIN 
YES 3 NO NO NO 
LABOUR 
NATURA 
3 3.7 3 NO NO 1 
337 VINITHA 24 
G2P1
L1 
4 
MEA
L 
PLAN 
NO 1 NO NO NO 
EMERGENC
Y LSCS 
3 3.8 3 NO NO 1 
338 
MAHALAX
MI 
38 
PRIM
I 
3 
INSU
LIN 
NO 2 NO NO NO 
ELECTIVE 
LSCS 
3 3.6 3 NO NO 2 
339 ROJA 26 
PRIM
I 
4 
INSU
LIN 
NO 1 NO NO NO 
LABOUR 
NATURA 
3 3.9 3 NO NO 1 
340 NANDHINI 28 
G2P1
L1 
4 
MEA
L 
PLAN 
YES 1 NO NO NO 
EMERGENC
Y LSCS 
1 2.9 1 NO 
YE
S 
1 
341 POWN 25 
G2P1
L1 
5 
INSU
LIN 
NO 2 NO NO NO 
ELECTIVE 
LSCS 
3 3.6 3 NO NO 1 
342 PERUNDEVI 19 
PRIM
I 
2 
MEA
L 
PLAN 
NO 1 NO NO NO 
LABOUR 
NATURA 
3 3.5 3 NO NO 1 
343 NAGAMA 24 
G2P1
L1 
4 
INSU
LIN 
NO 1 NO NO NO 
EMERGENC
Y LSCS 
3 3 3 NO NO 1 
344 JYOTHI 28 
PRIM
I 
4 
MEA
L 
PLAN 
NO 1 NO NO NO 
ELECTIVE 
LSCS 
3 3.8 3 NO NO 1 
345 RUPALA 34 
G2P1
L1 
4 
INSU
LIN 
NO 1 
YE
S 
NO NO 
ELECTIVE 
LSCS 
3 3.7 3 NO NO 2 
346 
MANONMA
NI 
31 
G2P1
L1 
4 
INSU
LIN 
YES 1 NO NO NO 
ELECTIVE 
LSCS 
3 3.6 3 NO NO 1 
347 
DHANALAX
MI 
26 
PRIM
I 
4 
MEA
L 
PLAN 
NO 2 NO NO NO 
EMERGENC
Y LSCS 
3 3.9 3 NO NO 1 
348 NAGAVENI 23 
PRIM
I 
4 
MEA
L 
PLAN 
NO 1 NO NO NO 
EMERGENC
Y LSCS 
3 3.7 3 NO NO 1 
349 SHANTHI 20 
PRIM
I 
3 
INSU
LIN 
NO 1 NO YES NO 
LABOUR 
NATURA 
3 2.2 3 NO NO 1 
350 VENNILA 24 
PRIM
I 
4 
MEA
L 
PLAN 
NO 3 NO NO NO 
EMERGENC
Y LSCS 
3 3.6 3 NO NO 1 
351 JAYAGOPI 26 
G2P1
L1 
3 
INSU
LIN 
NO 1 NO NO NO 
ELECTIVE 
LSCS 
3 3.5 3 NO NO 3 
352 GAYATHRI 25 
PRIM
I 
4 
MEA
L 
PLAN 
NO 1 NO NO NO 
EMERGENC
Y LSCS 
3 3.8 3 NO NO 1 
353 GOMATHI 32 
G2P1
L1 
4 
INSU
LIN 
NO 2 NO NO NO 
ELECTIVE 
LSCS 
3 3.9 3 NO NO 1 
354 VIJAYA 30 
G2P1
L1 
3 
INSU
LIN 
NO 1 NO NO NO 
ELECTIVE 
LSCS 
3 3.5 3 NO NO 2 
355 
AISHWARY
A 
28 
G2P1
L1 
4 
INSU
LIN 
NO 3 NO NO NO 
EMERGENC
Y LSCS 
3 2.9 3 NO NO 1 
356 UMA 24 
PRIM
I 
4 
MEA
L 
PLAN 
NO 1 NO NO NO 
EMERGENC
Y LSCS 
3 3.6 3 NO NO 1 
357 
MAHESWA
RI 
28 
G2P1
L1 
4 
INSU
LIN 
NO 1 NO NO NO 
EMERGENC
Y LSCS 
3 3.7 3 NO NO 1 
358 
KOTEESWA
RI 
38 
G4P3
L3 
5 
INSU
LIN 
NO 3 NO NO NO 
EMERGENC
Y LSCS 
3 3.8 3 NO NO 1 
359 SUMAYA 26 
PRIM
I 
3 
MEA
L 
PLAN 
YES 1 
YE
S 
YES NO 
LABOUR 
NATURA 
3 2.2 3 NO NO 3 
360 JAYANTHI 23 
PRIM
I 
4 
INSU
LIN 
YES 1 NO NO NO 
EMERGENC
Y LSCS 
3 3.9 3 NO NO 1 
361 MALA 26 
G2P1
L1 
4 
INSU
LIN 
NO 1 NO NO NO 
ELECTIVE 
LSCS 
3 3.8 3 NO NO 1 
362 VIJAYAM 31 
G2P1
L1 
2 
INSU
LIN 
NO 1 
YE
S 
YES NO 
LABOUR 
NATURA 
3 2.4 3 NO NO 1 
363 VAITHEGI 24 
PRIM
I 
3 
MEA
L 
PLAN 
NO 1 NO NO NO 
EMERGENC
Y LSCS 
3 3.8 3 NO NO 1 
364 VATCHALA 34 
G2P1
L1 
4 
INSU
LIN 
NO 3 NO NO NO 
EMERGENC
Y LSCS 
3 3.8 3 NO NO 2 
365 JANAKI 25 
PRIM
I 
4 
MEA
L 
PLAN 
NO 1 
YE
S 
NO NO 
LABOUR 
NATURA 
3 3.6 3 NO NO 1 
366 SUMATHY 32 
G4P3
L3 
4 
INSU
LIN 
NO 1 NO NO NO 
ELECTIVE 
LSCS 
3 4 3 NO NO 2 
367 PRIYA 24 
G2P1
L1 
4 
INSU
LIN 
NO 1 NO NO NO 
ELECTIVE 
LSCS 
3 4 2 NO 
YE
S 
1 
368 
PADMAVAT
HY 
28 
PRIM
I 
4 
INSU
LIN 
NO 1 NO NO YES 
LABOUR 
NATURA 
3 3.4 3 NO NO 1 
369 JAYA 24 
PRIM
I 
4 
MEA
L 
PLAN 
NO 2 NO NO NO 
EMERGENC
Y LSCS 
3 4.1 3 NO NO 1 
370 CHITRA 18 
G2P1
L1 
4 
INSU
LIN 
YES 1 NO NO NO 
LABOUR 
NATURA 
3 3.5 3 NO NO 1 
371 
MANIMEGA
LAI 
24 
G2P1
L1 
4 
INSU
LIN 
NO 3 NO NO NO 
ELECTIVE 
LSCS 
3 3.6 3 NO NO 2 
372 
MAHALAKS
HMI 
34 
G4P3
L3 
3 
INSU
LIN 
NO 2 
YE
S 
NO NO 
ELECTIVE 
LSCS 
3 3.5 3 NO NO 1 
373 
LINGESHW
ARI 
30 
PRIM
I 
4 
MEA
L 
PLAN 
NO 1 NO NO NO 
LABOUR 
NATURA 
3 3.6 3 NO NO 1 
374 LAVANYA 23 
G2P1
L1 
4 
INSU
LIN 
NO 1 NO NO NO 
EMERGENC
Y LSCS 
1 2.9 1 NO 
YE
S 
1 
375 MALATHY 26 
PRIM
I 
4 
INSU
LIN 
NO 3 NO NO NO 
EMERGENC
Y LSCS 
3 3.6 3 NO NO 2 
376 
BAGIYALAK
SHMI 
20 
G2P1
L1 
5 
INSU
LIN 
NO 1 NO NO NO 
LABOUR 
NATURA 
3 3.7 3 NO NO 1 
377 GEETHA 24 
PRIM
I 
2 
INSU
LIN 
NO 1 NO NO NO 
LABOUR 
NATURA 
3 3.8 3 NO NO 1 
378 KAMALA 25 
PRIM
I 
4 
MEA
L 
PLAN 
YES 1 NO NO NO 
INSTRUME
NTAL 
3 3.8 3 NO NO 1 
379 JANAKI 26 
G2P1
L1 
4 
INSU
LIN 
NO 1 NO NO NO 
EMERGENC
Y LSCS 
3 3.9 3 NO NO 1 
380 SEETHA 34 
G4P3
L3 
4 
INSU
LIN 
NO 1 NO NO NO 
LABOUR 
NATURA 
3 4 3 NO NO 1 
381 
GOVINDHA
MMAL 
28 
PRIM
I 
4 
MEA
L 
PLAN 
NO 2 NO NO NO 
EMERGENC
Y LSCS 
3 4.2 3 NO NO 1 
382 KOKILA 24 
G2P1
L1 
4 
INSU
LIN 
NO 3 NO NO YES 
EMERGENC
Y LSCS 
3 3.8 2 NO 
YE
S 
2 
383 LAKSHMI 38 
PRIM
I 
3 
MEA
L 
PLAN 
NO 1 NO NO NO 
LABOUR 
NATURA 
3 3.9 3 NO NO 1 
384 DEVI 26 
G2P1
L1 
4 
INSU
LIN 
NO 2 NO NO NO 
LABOUR 
NATURA 
3 3.9 3 NO NO 1 
385 SUCHITRA 32 
G4P3
L3 
4 
MEA
L 
PLAN 
NO 1 
YE
S 
NO NO 
LABOUR 
NATURA 
3 3.7 3 NO NO 1 
386 SUJATHA 26 
PRIM
I 
5 
INSU
LIN 
NO 1 NO NO NO 
INSTRUME
NTAL 
3 3.6 3 NO NO 1 
387 KUMARI 20 
G2P1
L1 
4 
INSU
LIN 
NO 1 NO NO YES 
LABOUR 
NATURA 
3 3.9 3 NO NO 1 
388 DEEPIKA 24 
PRIM
I 
3 
INSU
LIN 
NO 1 NO NO NO 
EMERGENC
Y LSCS 
3 4 3 NO NO 1 
389 LOGAMBAL 23 
G2P1
L1 
4 
MEA
L 
PLAN 
NO 1 NO NO YES 
LABOUR 
NATURA 
4 3.6 2 NO 
YE
S 
1 
390 SUPRIYA 32 
PRIM
I 
4 
INSU
LIN 
NO 1 NO NO NO 
EMERGENC
Y LSCS 
3 3.5 3 NO NO 3 
391 SRIDEVI 24 
G2P1
L1 
5 
INSU
LIN 
NO 2 NO NO NO 
EMERGENC
Y LSCS 
3 3.7 3 NO NO 1 
392 VIMALA 38 
G4P3
L3 
4 
INSU
LIN 
NO 1 NO NO NO 
LABOUR 
NATURA 
3 3.7 3 NO NO 1 
393 
LURTHAM
MAL 
24 
PRIM
I 
4 
MEA
L 
PLAN 
NO 1 NO NO NO 
EMERGENC
Y LSCS 
3 4.4 3 NO NO 1 
394 NANDHINI 25 
PRIM
I 
3 
INSU
LIN 
NO 1 NO NO NO 
EMERGENC
Y LSCS 
3 3.9 3 NO NO 1 
395 NAVEENA 18 
PRIM
I 
4 
MEA
L 
PLAN 
NO 1 NO NO NO 
EMERGENC
Y LSCS 
3 3.8 3 NO NO 1 
396 RUKMANI 34 
G4P3
L3 
4 
INSU
LIN 
NO 1 NO NO NO 
LABOUR 
NATURA 
3 2.9 2 NO NO 1 
397 BAKIYAM 28 
PRIM
I 
4 
MEA
L 
PLAN 
NO 1 NO NO YES 
INSTRUME
NTAL 
3 3.8 3 NO NO 1 
398 KRITHEGA 24 
PRIM
I 
4 
MEA
L 
PLAN 
NO 2 NO NO NO 
EMERGENC
Y LSCS 
3 3.6 3 NO NO 1 
399 
SUBULAKSH
MI 
38 
PRIM
I 
5 
INSU
LIN 
NO 1 
YE
S 
NO NO 
ELECTIVE 
LSCS 
3 3.6 3 NO NO 1 
400 SUGANYA. 32 
G4P3
L3 
3 
INSU
LIN 
NO 1 NO NO NO 
LABOUR 
NATURA 
3 3.6 3 NO NO 1 

